# EDGAR Filing Document

**Accession Number:** 0000008818
**File Stem:** 0000008818-25-000040
**Filing Date:** 2025-7
**Character Count:** 139207
**Document Hash:** 8b2444626cca23fcc5ff6c1432160139
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000008818-25-000040.hdr.sgml**: 20250729

**ACCESSION NUMBER**: 0000008818-25-000040

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 78

**CONFORMED PERIOD OF REPORT**: 20250628

**FILED AS OF DATE**: 20250729

**DATE AS OF CHANGE**: 20250729

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Avery Dennison Corp
- **CENTRAL INDEX KEY:** 0000008818
- **STANDARD INDUSTRIAL CLASSIFICATION:** CONVERTED PAPER & PAPERBOARD PRODS (NO CONTAINERS/BOXES) [2670]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 951492269
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-07685
- **FILM NUMBER:** 251161991

**BUSINESS ADDRESS:**
- **STREET 1:** 8080 NORTON PARKWAY
- **CITY:** MENTOR
- **STATE:** OH
- **ZIP:** 44060
- **BUSINESS PHONE:** 440-534-6000

**MAIL ADDRESS:**
- **STREET 1:** 8080 NORTON PARKWAY
- **CITY:** MENTOR
- **STATE:** OH
- **ZIP:** 44060

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AVERY DENNISON CORPORATION
- **DATE OF NAME CHANGE:** 19920703

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AVERY INTERNATIONAL CORP
- **DATE OF NAME CHANGE:** 19901030

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AVERY PRODUCTS CORP
- **DATE OF NAME CHANGE:** 19760518

?xml version='1.0' encoding='ASCII'? avy-20250628

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION** 

**WASHINGTON, DC 20549** 

**FORM 10-Q**

**(Mark One)**

⌧ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the quarterly period ended June 28, 2025.

**OR**

□ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the transition period from ________________________ to ________________________

**Commission file number 1-7685**

**AVERY DENNISON CORPORATION**

**(Exact name of registrant as specified in its charter)**

---

| | |
|:---|:---|
| **Delaware** | **95-1492269** |
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
| **8080 Norton Parkway**<br>**Mentor, Ohio** | **44060** |
| (Address of Principal Executive Offices) | (Zip Code) |

---

Registrant's telephone number, including area code: (440) 534-6000

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common stock, $1 par value | AVY | New York Stock Exchange |
| 3.75% Senior Notes due 2034 | AVY34 | Nasdaq Stock Market |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ⌧ No □

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ⌧ No □

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

⌧ Large accelerated filer □ Accelerated filer □ Non-accelerated filer □ Smaller reporting company □ Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ⌧

Number of shares of $1 par value common stock outstanding as of July 26, 2025: 77,981,594

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

**AVERY DENNISON CORPORATION** 

**FISCAL SECOND QUARTER 2025 QUARTERLY REPORT ON FORM 10-Q**

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| | | **Page** |
| **<u>[SAFE HARBOR STATEMENT](#ib07a0b00f720416bae77b66ae569d11e_10)</u>** | **<u>[SAFE HARBOR STATEMENT](#ib07a0b00f720416bae77b66ae569d11e_10)</u>** | [1](#ib07a0b00f720416bae77b66ae569d11e_10) |
| **<u>[PART I. FINANCIAL INFORMATION (UNAUDITED)](#ib07a0b00f720416bae77b66ae569d11e_13)</u>** | **<u>[PART I. FINANCIAL INFORMATION (UNAUDITED)](#ib07a0b00f720416bae77b66ae569d11e_13)</u>** |  |
| [Item 1.](#ib07a0b00f720416bae77b66ae569d11e_16) | <u>[Financial Statements:](#ib07a0b00f720416bae77b66ae569d11e_16)</u> |  |
|  | &nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Balance Sheets as of](#ib07a0b00f720416bae77b66ae569d11e_19)[June 28](#ib07a0b00f720416bae77b66ae569d11e_19)[, 2025 and December 28, 2024](#ib07a0b00f720416bae77b66ae569d11e_19)</u> | [2](#ib07a0b00f720416bae77b66ae569d11e_19) |
|  | &nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Income for the Three](#ib07a0b00f720416bae77b66ae569d11e_22)[and Six](#ib07a0b00f720416bae77b66ae569d11e_22)[Months Ended](#ib07a0b00f720416bae77b66ae569d11e_22)[June 28](#ib07a0b00f720416bae77b66ae569d11e_22)[, 2025 and](#ib07a0b00f720416bae77b66ae569d11e_22)[June 29](#ib07a0b00f720416bae77b66ae569d11e_22)[, 2024](#ib07a0b00f720416bae77b66ae569d11e_22)</u> | [3](#ib07a0b00f720416bae77b66ae569d11e_22) |
|  | &nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Comprehensive Income for the Three](#ib07a0b00f720416bae77b66ae569d11e_25)[and Six](#ib07a0b00f720416bae77b66ae569d11e_25)[Months Ended](#ib07a0b00f720416bae77b66ae569d11e_25)[June 28](#ib07a0b00f720416bae77b66ae569d11e_25)[, 2025 and](#ib07a0b00f720416bae77b66ae569d11e_25)[June 29](#ib07a0b00f720416bae77b66ae569d11e_25)[, 2024](#ib07a0b00f720416bae77b66ae569d11e_25)</u> | [4](#ib07a0b00f720416bae77b66ae569d11e_25) |
|  | &nbsp;&nbsp;&nbsp;<u>[Condensed Consolidated Statements of Cash Flows for the](#ib07a0b00f720416bae77b66ae569d11e_28)[S](#ib07a0b00f720416bae77b66ae569d11e_28)[ix](#ib07a0b00f720416bae77b66ae569d11e_28)[Months Ended](#ib07a0b00f720416bae77b66ae569d11e_28)[June 28](#ib07a0b00f720416bae77b66ae569d11e_28)[, 2025 and](#ib07a0b00f720416bae77b66ae569d11e_28)[June 29](#ib07a0b00f720416bae77b66ae569d11e_28)[, 2024](#ib07a0b00f720416bae77b66ae569d11e_28)</u> | [5](#ib07a0b00f720416bae77b66ae569d11e_28) |
|  | &nbsp;&nbsp;&nbsp;<u>[Notes to Unaudited Condensed Consolidated Financial Statements](#ib07a0b00f720416bae77b66ae569d11e_31)</u> | [6](#ib07a0b00f720416bae77b66ae569d11e_31) |
| [Item 2.](#ib07a0b00f720416bae77b66ae569d11e_79) | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#ib07a0b00f720416bae77b66ae569d11e_79)</u> | [18](#ib07a0b00f720416bae77b66ae569d11e_79) |
|  | &nbsp;&nbsp;&nbsp;<u>[Non-GAAP Financial Measures](#ib07a0b00f720416bae77b66ae569d11e_82)</u> | [18](#ib07a0b00f720416bae77b66ae569d11e_82) |
|  | &nbsp;&nbsp;&nbsp;<u>[Overview and Outlook](#ib07a0b00f720416bae77b66ae569d11e_85)</u> | [19](#ib07a0b00f720416bae77b66ae569d11e_85) |
|  | &nbsp;&nbsp;&nbsp;<u>[Analysis of Results of Operations for the](#ib07a0b00f720416bae77b66ae569d11e_88)[Second](#ib07a0b00f720416bae77b66ae569d11e_88)[Quarter](#ib07a0b00f720416bae77b66ae569d11e_88)</u> | [20](#ib07a0b00f720416bae77b66ae569d11e_88) |
|  | &nbsp;&nbsp;&nbsp;<u>[Results of Operations by Reportable Segment for the](#ib07a0b00f720416bae77b66ae569d11e_91)[Second](#ib07a0b00f720416bae77b66ae569d11e_91)[Quarter](#ib07a0b00f720416bae77b66ae569d11e_91)</u> | [22](#ib07a0b00f720416bae77b66ae569d11e_91) |
|  | &nbsp;&nbsp;&nbsp;<u>[Analysis of Results of Operations for the](#ib07a0b00f720416bae77b66ae569d11e_94)[Six](#ib07a0b00f720416bae77b66ae569d11e_94)[Months Year-to-Date](#ib07a0b00f720416bae77b66ae569d11e_94)</u> | [23](#ib07a0b00f720416bae77b66ae569d11e_94) |
|  | &nbsp;&nbsp;&nbsp;<u>[Results of Operations by Reportable Segment for the](#ib07a0b00f720416bae77b66ae569d11e_97)[Six](#ib07a0b00f720416bae77b66ae569d11e_97)[Months Year-to-Date](#ib07a0b00f720416bae77b66ae569d11e_97)</u> | [24](#ib07a0b00f720416bae77b66ae569d11e_97) |
|  | &nbsp;&nbsp;&nbsp;<u>[Financial Condition](#ib07a0b00f720416bae77b66ae569d11e_100)</u> | [26](#ib07a0b00f720416bae77b66ae569d11e_100) |
| [Item 3.](#ib07a0b00f720416bae77b66ae569d11e_103) | <u>[Quantitative and Qualitative Disclosures About Market Risk](#ib07a0b00f720416bae77b66ae569d11e_103)</u> | [29](#ib07a0b00f720416bae77b66ae569d11e_103) |
| [Item 4.](#ib07a0b00f720416bae77b66ae569d11e_106) | <u>[Controls and Procedures](#ib07a0b00f720416bae77b66ae569d11e_106)</u> | [30](#ib07a0b00f720416bae77b66ae569d11e_106) |
| **<u>[PART II. OTHER INFORMATION](#ib07a0b00f720416bae77b66ae569d11e_109)</u>** | **<u>[PART II. OTHER INFORMATION](#ib07a0b00f720416bae77b66ae569d11e_109)</u>** |  |
| [Item 1.](#ib07a0b00f720416bae77b66ae569d11e_112) | <u>[Legal Proceedings](#ib07a0b00f720416bae77b66ae569d11e_112)</u> | [31](#ib07a0b00f720416bae77b66ae569d11e_112) |
| [Item 1A.](#ib07a0b00f720416bae77b66ae569d11e_115) | <u>[Risk Factors](#ib07a0b00f720416bae77b66ae569d11e_115)</u> | [31](#ib07a0b00f720416bae77b66ae569d11e_115) |
| [Item 2.](#ib07a0b00f720416bae77b66ae569d11e_118) | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#ib07a0b00f720416bae77b66ae569d11e_118)</u> | [32](#ib07a0b00f720416bae77b66ae569d11e_118) |
| [Item 3.](#ib07a0b00f720416bae77b66ae569d11e_121) | <u>[Defaults Upon Senior Securities](#ib07a0b00f720416bae77b66ae569d11e_121)</u> | [32](#ib07a0b00f720416bae77b66ae569d11e_121) |
| [Item 4.](#ib07a0b00f720416bae77b66ae569d11e_124) | <u>[Mine Safety Disclosures](#ib07a0b00f720416bae77b66ae569d11e_124)</u> | [32](#ib07a0b00f720416bae77b66ae569d11e_124) |
| [Item 5.](#ib07a0b00f720416bae77b66ae569d11e_127) | <u>[Other Information](#ib07a0b00f720416bae77b66ae569d11e_127)</u> | [32](#ib07a0b00f720416bae77b66ae569d11e_127) |
| [Item 6.](#ib07a0b00f720416bae77b66ae569d11e_133) | <u>[Exhibits](#ib07a0b00f720416bae77b66ae569d11e_133)</u> | [33](#ib07a0b00f720416bae77b66ae569d11e_133) |
| <u>[Signatures](#ib07a0b00f720416bae77b66ae569d11e_136)</u> |  | [34](#ib07a0b00f720416bae77b66ae569d11e_136) |
| Exhibits |  |  |

---

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

**Safe Harbor Statement** 

This Quarterly Report contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements, which are not statements of historical fact, contain estimates, assumptions, projections and/or expectations regarding future events, which may or may not occur. Words such as "aim," "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "foresee," "guidance," "intend," "may," "might," "objective," "plan," "potential," "project," "seek," "shall," "should," "target," "will," "would," or variations thereof, and other expressions that refer to future events and trends, identify forward-looking statements. Our forward-looking statements, and financial or other business targets, are subject to certain risks and uncertainties, which could cause our actual results to differ materially from the expected results, performance or achievements expressed or implied by such forward-looking statements.

We believe that the most significant risk factors that could affect our financial performance in the near term include: (i) the impact on underlying demand for our products from global economic conditions, tariffs, geopolitical uncertainty, and changes in environmental standards, regulations, and preferences; (ii) competitors' actions, including pricing, expansion in key markets, and product offerings; (iii) the cost and availability of raw materials; (iv) the degree to which higher costs can be offset with productivity measures and/or passed on to customers through price increases, without a significant loss of volume; (v) foreign currency fluctuations; and (vi) the execution and integration of acquisitions.

Certain risks and uncertainties are discussed in more detail under "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our 2024 Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on February 26, 2025, and subsequent quarterly reports on Form 10-Q. Actual results and trends may differ materially from historical or anticipated results depending on a variety of factors, including but not limited to, risks and uncertainties related to the following:

• International Operations – worldwide economic, social, geopolitical and market conditions; changes in geopolitical conditions, including those related to trade relations and tariffs, China, the Russia-Ukraine war, the Israel-Hamas war and related hostilities in the Middle East; fluctuations in foreign currency exchange rates; and other risks associated with international operations, including in emerging markets

• Our Business – fluctuations in demand affecting sales to customers; fluctuations in the cost and availability of raw materials and energy; changes in our markets due to competitive conditions, technological developments, laws and regulations, and customer preferences; environmental regulations and sustainability trends; the impact of competitive products and pricing; the execution and integration of acquisitions; selling prices; customer and supplier concentrations or consolidations; the financial condition of distributors; outsourced manufacturers; product and service quality claims; restructuring and other cost reduction actions; our ability to generate sustained productivity improvement and our ability to achieve and sustain targeted cost reductions; the timely development and market acceptance of new products, including sustainable or sustainably-sourced products; our investment in development activities and new production facilities; the collection of receivables from customers; and our sustainability and governance practices

• Information Technology – disruptions in information technology systems; cybersecurity events or other security breaches; and successful installation of new or upgraded information technology systems

• Income Taxes – fluctuations in tax rates; changes in tax laws and regulations, and uncertainties associated with interpretations of such laws and regulations; outcome of tax audits; and the realization of deferred tax assets

• Human Capital – recruitment and retention of employees and collective labor arrangements

• Our Indebtedness – our ability to obtain adequate financing arrangements and maintain access to capital; credit rating risks; fluctuations in interest rates; and compliance with our debt covenants

• Ownership of Our Stock – potential significant variability of our stock price and amounts of future dividends and share repurchases

• Legal and Regulatory Matters – protection and infringement of our intellectual property; the impact of legal and regulatory proceedings, including with respect to compliance and anti-corruption, environmental, health and safety, and trade compliance

• Other Financial Matters – fluctuations in pension costs and goodwill impairment

Our forward-looking statements are made only as of the filing date of this Form 10-Q. We assume no duty to update these forward-looking statements to reflect new, changed or unanticipated events or circumstances, other than as may be required by law.

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

**PART I. FINANCIAL INFORMATION**

**ITEM 1. FINANCIAL STATEMENTS**

**CONDENSED CONSOLIDATED BALANCE SHEETS** 

**(*Unaudited*)** 

---

| | | |
|:---|:---|:---|
| (Dollars in millions, except per share amount) | **June 28, 2025** | **December 28, 2024** |
| **Assets** |  |  |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $215.9 | $329.1 |
| &nbsp;&nbsp;&nbsp;Trade accounts receivable, less allowances of $30.2 and $29.0 at June 28, 2025 and December 28, 2024, respectively | 1626.5 | 1466.2 |
| &nbsp;&nbsp;&nbsp;Inventories | 1026.9 | 978.1 |
| &nbsp;&nbsp;&nbsp;Other current assets | 314.5 | 305.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 3183.8 | 3078.7 |
| Property, plant and equipment, net | 1604.2 | 1586.7 |
| Goodwill | 2028.2 | 1976.2 |
| Other intangibles resulting from business acquisitions, net | 716.4 | 755.3 |
| Deferred tax assets | 131.6 | 110.0 |
| Other assets | 904.0 | 897.3 |
| Total assets | $8568.2 | $8404.2 |
| **Liabilities and Shareholders' Equity** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Short-term borrowings and current portion of long-term debt and finance leases | $922.0 | $592.3 |
| &nbsp;&nbsp;&nbsp;Accounts payable | 1307.5 | 1340.7 |
| &nbsp;&nbsp;&nbsp;Accrued payroll and employee benefits | 205.3 | 288.9 |
| &nbsp;&nbsp;&nbsp;Other current liabilities | 627.3 | 640.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 3062.1 | 2862.6 |
| Long-term debt and finance leases | 2628.2 | 2559.9 |
| Long-term retirement benefits and other liabilities | 448.2 | 434.6 |
| Deferred tax liabilities and income taxes payable | 228.1 | 234.8 |
| Commitments and contingencies (see Note 10) |  |  |
| Shareholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;Common stock, $1 par value per share, authorized – 400,000,000 shares at June 28, 2025 and December 28, 2024; issued – 124,126,624 shares at June 28, 2025 and December 28, 2024; outstanding – 78,044,822 shares and 79,800,396 shares at June 28, 2025 and December 28, 2024, respectively | 124.1 | 124.1 |
| &nbsp;&nbsp;&nbsp;Capital in excess of par value | 821.9 | 840.6 |
| &nbsp;&nbsp;&nbsp;Retained earnings | 5399.3 | 5151.2 |
| &nbsp;&nbsp;&nbsp;Treasury stock at cost, 46,081,802 shares and 44,326,228 shares at June 28, 2025 and December 28, 2024, respectively | (3693.7) | (3347.5) |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (450.0) | (456.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total shareholders' equity | 2201.6 | 2312.3 |
| Total liabilities and shareholders' equity | $8568.2 | $8404.2 |

---

See Notes to Unaudited Condensed Consolidated Financial Statements

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

**CONDENSED CONSOLIDATED STATEMENTS OF INCOME** 

**(*Unaudited*)** 

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|<br>(In millions, except per share amounts) | **June 28, 2025** | **June 29, 2024** | **June 28, 2025** | **June 29, 2024** |
| Net sales | $2220.5 | $2235.3 | $4368.8 | $4386.6 |
| Cost of products sold | 1581.4 | 1572.6 | 3108.2 | 3091.7 |
| &nbsp;&nbsp;&nbsp;Gross profit | 639.1 | 662.7 | 1260.6 | 1294.9 |
| Marketing, general and administrative expense | 352.4 | 373.9 | 699.4 | 739.1 |
| Other expense (income), net | .5 | 27.0 | 20.4 | 39.6 |
| Interest expense | 34.0 | 29.2 | 64.9 | 57.8 |
| Other non-operating expense (income), net | (3.3) | (5.8) | (6.6) | (14.4) |
| &nbsp;&nbsp;&nbsp;Income before taxes | 255.5 | 238.4 | 482.5 | 472.8 |
| Provision for income taxes | 66.5 | 61.6 | 127.2 | 123.6 |
| Net income | $189.0 | $176.8 | $355.3 | $349.2 |
| Per share amounts: |  |  |  |  |
| Net income per common share | $2.42 | $2.19 | $4.51 | $4.34 |
| Net income per common share, assuming dilution | $2.41 | $2.18 | $4.50 | $4.31 |
| Weighted average number of shares outstanding: |  |  |  |  |
| Common shares | 78.2 | 80.6 | 78.7 | 80.5 |
| Common shares, assuming dilution | 78.3 | 81.0 | 78.9 | 81.0 |

---

See Notes to Unaudited Condensed Consolidated Financial Statements

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

**CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME** 

**(*Unaudited*)** 

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|<br>(In millions) | **June 28, 2025** | **June 29, 2024** | **June 28, 2025** | **June 29, 2024** |
| Net income | $189.0 | $176.8 | $355.3 | $349.2 |
| Other comprehensive income (loss), net of tax: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency translation | (.5) | (17.8) | 2.4 | (29.7) |
| &nbsp;&nbsp;&nbsp;Pension and other postretirement benefits | .5 | .2 | 1.1 | .4 |
| &nbsp;&nbsp;&nbsp;Cash flow hedges | (1.2) | 1.9 | 3.7 | (.3) |
| &nbsp;&nbsp;&nbsp;Fair value hedges | .4 |  | (1.1) |  |
| Other comprehensive income (loss), net of tax | (.8) | (15.7) | 6.1 | (29.6) |
| Total comprehensive income, net of tax | $188.2 | $161.1 | $361.4 | $319.6 |

---

See Notes to Unaudited Condensed Consolidated Financial Statements

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS** 

***(Unaudited*)** 

---

| | | |
|:---|:---|:---|
| | **Six Months Ended** | **Six Months Ended** |
| (In millions) | **June 28, 2025** | **June 29, 2024** |
| **Operating Activities** |  |  |
| Net income | $355.3 | $349.2 |
| Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation | 100.3 | 98.7 |
| &nbsp;&nbsp;&nbsp;Amortization | 58.4 | 57.2 |
| &nbsp;&nbsp;&nbsp;Provision for credit losses and sales returns | 25.3 | 28.2 |
| &nbsp;&nbsp;&nbsp;Stock-based compensation | 14.7 | 17.4 |
| &nbsp;&nbsp;&nbsp;Deferred taxes and other non-cash taxes | (12.0) | (3.8) |
| &nbsp;&nbsp;&nbsp;Other non-cash expense and loss (income and gain), net | 20.8 | 46.6 |
| Changes in assets and liabilities and other adjustments | (370.3) | (276.0) |
| Net cash provided by operating activities | 192.5 | 317.5 |
| **Investing Activities** |  |  |
| Purchases of property, plant and equipment | (66.0) | (96.3) |
| Purchases of software and other deferred charges | (15.2) | (12.9) |
| Purchases of Argentine Blue Chip Swap securities |  | (34.2) |
| Proceeds from sales of Argentine Blue Chip Swap securities |  | 24.0 |
| Proceeds from sales of property, plant and equipment | 15.7 | .3 |
| Proceeds from insurance and sales (purchases) of investments, net | 8.8 | 2.2 |
| Proceeds from settlement of net investment hedges  | 6.2 |  |
| Payments for acquisitions, net of cash acquired, and venture investments | (10.7) | (1.9) |
| Net cash used in investing activities | (61.2) | (118.8) |
| **Financing Activities** |  |  |
| Net increase (decrease) in borrowings with maturities of three months or less | 816.2 | (2.2) |
| Repayments of long-term debt and finance leases | (551.6) | (3.5) |
| Dividends paid | (142.9) | (136.2) |
| Share repurchases | (360.0) | (40.7) |
| Net (tax withholding) proceeds related to stock-based compensation | (12.6) | (18.4) |
| Payments for settlement of fair value hedges | (13.5) |  |
| Other | 15.9 | (1.1) |
| Net cash used in financing activities | (248.5) | (202.1) |
| Effect of foreign currency translation on cash balances | 4.0 | (2.8) |
| Increase (decrease) in cash and cash equivalents | (113.2) | (6.2) |
| Cash and cash equivalents, beginning of year | 329.1 | 215.0 |
| Cash and cash equivalents, end of period | $215.9 | $208.8 |

---

See Notes to Unaudited Condensed Consolidated Financial Statements

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

**<u>NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</u>**

**Note 1. General** 

The unaudited Condensed Consolidated Financial Statements and related notes in this Quarterly Report on Form 10-Q are presented as permitted by Article 10 of Regulation S-X and do not contain certain information included in the audited Consolidated Financial Statements and related notes in our 2024 Annual Report on Form 10-K, which should be read in conjunction with this report. These unaudited Condensed Consolidated Financial Statements contain all adjustments of a normal and recurring nature necessary for a fair statement of our interim results. Interim results of operations are not necessarily indicative of the results expected for the full fiscal year or any future period. These unaudited Condensed Consolidated Financial Statements reflect our current estimates and assumptions affecting (i) our reported amounts of assets and liabilities and related disclosures as of the date of the financial statements and (ii) our reported amounts of sales and expenses during the reporting periods presented.

***Fiscal Periods***

The three and six months ended June 28, 2025 and June 29, 2024 each consisted of thirteen- and twenty-six week periods, respectively.

In January 2025, the Audit Committee of our Board of Directors approved a change to our previous 52- or 53-week fiscal year generally ending on the Saturday closest to December 31 to a fiscal year coincident with the calendar year. Our 2025 fiscal year that began on December 29, 2024 will end on December 31, 2025 and fiscal years 2026 and beyond will begin on January 1 and end on December 31.

***Reclassifications***

Certain prior-period amounts have been reclassified to conform to the current-year presentation. Refer to Note 11, "Segment and Disaggregated Revenue Information," to the unaudited Condensed Consolidated Financial Statements for more information.

***Accounting Guidance Update***

In the first quarter of 2025 we adopted guidance related to the accounting for and disclosure of crypto assets. The impact of this adoption was not material to our financial statements or disclosures.

**Note 2. Goodwill and Other Intangibles Resulting from Business Acquisitions**

Changes in the net carrying amount of goodwill for the six months ended June 28, 2025 by reportable segment are shown below.

---

| | | | |
|:---|:---|:---|:---|
| (In millions) | **Materials Group** | **Solutions Group** | **Total** |
| Goodwill as of December 28, 2024 | $606.1 | $1370.1 | $1976.2 |
| Translation adjustments | 38.6 | 13.4 | 52.0 |
| Goodwill as of June 28, 2025 | $644.7 | $1383.5 | $2028.2 |

---

Amortization expense for finite-lived intangible assets resulting from business acquisitions was $22.1 million and $22.3 million for the three months ended June 28, 2025 and June 29, 2024, respectively, and $44.2 million and $44.7 million for the six months ended June 28, 2025 and June 29, 2024, respectively.

Estimated future amortization expense related to existing finite-lived intangible assets for the remainder of fiscal year 2025 and for each of the next four fiscal years and thereafter is shown below.

---

| | |
|:---|:---|
| (In millions) | **Estimated<br>Amortization <br>Expense** |
| 2025 (remainder of year) | $44.4 |
| 2026 | 85.9 |
| 2027 | 85.6 |
| 2028 | 77.8 |
| 2029 | 62.3 |
| 2030 and thereafter | 204.4 |

---

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

**Note 3. Debt** 

In the first quarter of 2025, we repaid our €500 million of senior notes at maturity using the net proceeds from the €500 million of senior notes we issued in the fourth quarter of 2024, cash flows from operations and commercial paper borrowings.

In the second quarter of 2025, we repaid our $25 million of medium-term notes at maturity using cash flows from operations and commercial paper borrowings.

During 2024, we entered into foreign currency forward contracts that we designated as fair value hedges to hedge a portion of the principal balance of our euro-denominated debt that offset changes in the fair value of the hedged item attributable to foreign currency risk. These foreign currency forward contracts related to our €500 million of senior notes that matured in the first quarter of 2025 and were settled at that time. Refer to Note 5, "Financial Instruments," to the unaudited Condensed Consolidated Financial Statements for more information.

The estimated fair value of our long-term debt is primarily based on the credit spread above U.S. Treasury securities or euro government bond securities, as applicable, on notes with similar rates, credit ratings and remaining maturities. The fair value of short-term borrowings, which include commercial paper issuances and short-term lines of credit, approximates their carrying value given the short duration of these obligations. The fair value of our total debt was $3.45 billion at June 28, 2025 and $3.01 billion at December 28, 2024. Fair value was determined based primarily on Level 2 inputs, which are inputs other than quoted prices in active markets that are either directly or indirectly observable.

Our $1.20 billion revolving credit facility (the "Revolver") contains a financial covenant requiring that we maintain a specified ratio of total debt minus unrestricted cash and cash equivalents in excess of $50 million to a certain measure of income. As of both June 28, 2025 and December 28, 2024, we were in compliance with this financial covenant. No balance was outstanding under the Revolver as of June 28, 2025 or December 28, 2024.

**Note 4. Cost Reduction Actions** 

*2025 Actions*

We recorded $12.9 million in restructuring charges, net of reversals, during the six months ended June 28, 2025. These charges consisted of severance and related costs for the reduction of approximately 460 positions, as well as asset impairment charges, at various locations across our company. Our 2025 actions are primarily intended to optimize our operational footprint.

During the six months ended June 28, 2025, restructuring charges and payments were as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| (In millions) | **Accrual at**<br>**December 28, 2024** | **Charges,**<br>**Net of**<br>**Reversals** | **Cash**<br>**Payments** | **Non-cash**<br>**Impairment** | **Foreign**<br>**Currency**<br>**Translation** | **Accrual at**<br>**June 28, 2025** |
| **2025 Actions** |  |  |  |  |  |  |
| Severance and related costs | $10.0 | $12.6 | $(19.9) | $— | $— | $2.7 |
| Asset impairment charges |  | .2 |  | (.2) |  |  |
| Lease cancellation charges |  | .1 | (.1) |  |  |  |
| Total | $10.0 | $12.9 | $(20.0) | $(.2) | $— | $2.7 |

---

Accruals for severance and related costs, as well as lease cancellation charges, were included in "Other current liabilities" and "Long-term retirement benefits and other liabilities" in the unaudited Condensed Consolidated Balance Sheets. Asset impairment charges were based on the estimated market value of the assets, less selling costs, if applicable. Restructuring charges were included in "Other expense (income), net" in the unaudited Condensed Consolidated Statements of Income.

The table below shows the total amount of restructuring charges, net of reversals, incurred by reportable segment and Corporate.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|<br>(In millions) | **June 28, 2025** | **June 29, 2024** | **June 28, 2025** | **June 29, 2024** |
| **Restructuring charges, net of reversals, by reportable segment and Corporate** |  |  |  |  |
| Materials Group | $2.5 | $1.6 | $5.0 | $4.1 |
| Solutions Group | 5.2 | 5.4 | 7.2 | 8.8 |
| Corporate | .3 | .2 | .7 | .3 |
| Total | $8.0 | $7.2 | $12.9 | $13.2 |

---

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

**Note 5. Financial Instruments** 

We use various derivative financial instruments to manage risks in foreign currency exchange rates, commodity prices and interest rates. We recognize derivative financial instruments as either assets or liabilities at fair value in the unaudited Condensed Consolidated Balance Sheets. Refer to Note 9, "Fair Value Measurements," to the unaudited Condensed Consolidated Financial Statements for more information.

***Fair Value Hedges***

During 2024, we entered into foreign currency forward contracts to hedge a portion of the principal balance of our €500 million of senior notes that matured in the first quarter of 2025 and €500 million of senior notes due in the fourth quarter of 2034 to offset changes in the fair value of the hedged item attributable to foreign currency risk. The foreign currency forward contracts hedging our €500 million of senior notes due in the fourth quarter of 2034 mature in December 2025.

Refer to Note 3, "Debt," to the unaudited Condensed Consolidated Financial Statements for more information.

***Cash Flow Hedges***

During 2020, we entered into U.S. dollar to euro cross-currency swap contracts to effectively convert our fixed-rate U.S. dollar-denominated debt to euro-denominated debt, including semiannual interest payments and the payment of principal at maturity. During the term of the contracts, which end on April 30, 2030, we pay fixed-rate interest in euros and receive fixed-rate interest in U.S. dollars.

We designate commodity forward contracts on forecasted purchases of commodities as cash flow hedges. The impact of these commodity hedge activities on the unaudited Condensed Consolidated Financial Statements was not material.

***Net Investment Hedges***

During 2024, we entered into foreign currency forward contracts and zero-cost collars, combining each pair as net investment hedges for accounting purposes, to minimize the effect of foreign currency exchange rates on our net investment in certain foreign operations between the sold put strike and the bought call strike rates of the contracts. The notional amount of the hedges, which mature in December 2025, was €500 million at June 28, 2025.

***Other Derivatives***

We enter into foreign currency exchange contracts to reduce the risk from foreign currency exchange rate fluctuations associated with our receivables, payables, loans and firm commitments denominated in certain foreign currencies that arise primarily as a result of our operations outside the U.S. The impact of these foreign currency exchange on the unaudited Condensed Consolidated Financial Statements was not material.

The following table shows the fair value and balance sheet locations of our fair value hedges, cross-currency swap contracts designated as cash flow hedges and net investment hedges as of June 28, 2025 and December 28, 2024:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| (In millions) | **Notional Amount** | **Other Current Assets** | **Other Non-Current Assets** | **Other Current Liabilities** | **Other Non-Current Liabilities** | **Type of Hedge** |
| June 28, 2025 |  |  |  |  |  |  |
| &nbsp;&nbsp;Derivatives designated as hedges: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency forward contracts | $585.8 | $35.8 | $— | $— | $— | Fair value |
| &nbsp;&nbsp;&nbsp;&nbsp;Cross-currency swap contracts | 250.0 |  |  |  | 12.7 | Cash flow |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency forward contracts with collars | 585.8 |  |  | 17.5 |  | Net investment |
| Total |  | $35.8 | $— | $17.5 | $12.7 |  |
| December 28, 2024 |  |  |  |  |  |  |
| &nbsp;&nbsp;Derivatives designated as hedges: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency forward contracts | $958.9 | $.2 | $— | $36.7 | $— | Fair value |
| &nbsp;&nbsp;&nbsp;&nbsp;Cross-currency swap contracts | 250.0 |  | 10.9 |  |  | Cash flow |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency forward contracts with collars | 958.9 | 17.8 |  | .2 |  | Net investment |
| Total |  | $18.0 | $10.9 | $36.9 | $— |  |

---

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

The following table shows the components of net gains (losses) recognized in income related to derivative instruments:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|<br>(In millions) | **June 28, 2025** | **June 29, 2024** | **June 28, 2025** | **June 29, 2024** |
| Gain (loss) on derivatives designated as fair value hedges: |  |  |  |  |
| &nbsp;&nbsp;Foreign currency forward contracts - Marketing, general and administrative expense | $46.4 | $— | $66.3 | $— |

---

The impact of the hedged items associated with the derivative in the table above is recorded to the same income statement line as the derivative instrument. The net gains (losses) recognized in income related to our cross-currency swap contracts were not material to the unaudited Condensed Consolidated Statements of Income for the three and six months ended June 28, 2025 and June 29, 2024.

The loss recognized in translation for the net investment hedges was approximately $27 million and $35 million for the three and six months ended June 28, 2025, respectively.

**Note 6. Taxes Based on Income** 

The following table summarizes our income before taxes, provision for income taxes, and effective tax rate:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|<br>(Dollars in millions) | **June 28, 2025** | **June 29, 2024** | **June 28, 2025** | **June 29, 2024** |
| Income before taxes | $255.5 | $238.4 | $482.5 | $472.8 |
| Provision for income taxes | 66.5 | 61.6 | 127.2 | 123.6 |
| Effective tax rate | 26.0% | 25.8% | 26.4% | 26.1% |

---

Our provision for income taxes for the three and six months ended June 28, 2025 included a net tax charge related to the tax on global intangible low-taxed income ("GILTI") of our foreign subsidiaries and the recognition of foreign withholding taxes on current year earnings, partially offset by the benefit from foreign-derived intangible income ("FDII"). Our provision for income taxes for these periods also included a discrete benefit from decreases in certain tax reserves, including interest and penalties, primarily as a result of closing tax years. In addition, our provision for income taxes for the six months ended June 28, 2025 included a discrete benefit from a favorable ruling related to deductibility of interest expense in a foreign jurisdiction.

During the second quarter of 2025, we received a court decision denying our application of incentive tax rates in a foreign jurisdiction for the 2016-2019 tax years. While we continue to evaluate our options, including further appeal, we amended our tax returns for subsequent tax years to mitigate potential penalties reflecting the change in our judgment with respect to applicable uncertain tax positions. This change had no adverse impact on our provision for income taxes or cash flows as taxes were previously paid at regular tax rates.

Our provision for income taxes for the three and six months ended June 29, 2024 included a net tax charge related to the tax on GILTI of our foreign subsidiaries and the recognition of foreign withholding taxes on current year earnings, partially offset by the benefit from FDII. In addition, our provision for income taxes for these periods was also favorably affected by (i) higher tax incentives in certain foreign jurisdictions and the tax impacts resulting from Blue Chip Swap transactions in Argentina and (ii) discrete tax benefits from decreases in certain tax reserves, including interest and penalties, as a result of closing tax years.

The amount of income taxes we pay is subject to ongoing audits by taxing jurisdictions around the world. Our estimate of the potential outcome of any uncertain tax issue is subject to our assessment of the relevant risks, facts and circumstances existing at the time. We believe that we have adequately provided for reasonably foreseeable outcomes related to these matters. However, our future results may include favorable or unfavorable adjustments to our estimated tax liabilities in the period the assessments are made or resolved, which may impact our effective tax rate. The final determination of tax audits and any related legal proceedings could materially differ from the amounts currently reflected in our tax provision for income taxes and the related liabilities. We and our U.S. subsidiaries have completed the Internal Revenue Service Compliance Assurance Process through 2022. With limited exceptions, we are no longer subject to income tax examinations by tax authorities for years prior to 2010.

Subsequent to the end of the second quarter of 2025, the U.S. government enacted a reconciliation bill, commonly referred to as the "One Big Beautiful Bill Act," which, among other things, included allowance of elective deductions for domestic research and development expenditures, a reinstatement of elective bonus depreciation, and modifications to certain international tax provisions. While we are in the process of evaluating the impact of this new legislation, we currently do not expect it to have a material impact to our financial statements or disclosures.

It is reasonably possible that, during the next 12 months, we may realize a net decrease in our uncertain tax positions, including interest and penalties, of approximately $3 million, primarily as a result of closing tax years.

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

**Note 7. Net Income Per Common Share**

Net income per common share was computed as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|<br>(In millions, except per share amounts) | **June 28, 2025** | **June 29, 2024** | **June 28, 2025** | **June 29, 2024** |
| (A)Net income | $189.0 | $176.8 | $355.3 | $349.2 |
| (B)Weighted average number of common shares outstanding | 78.2 | 80.6 | 78.7 | 80.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dilutive shares (additional common shares issuable under stock-based awards) | .1 | .4 | .2 | .5 |
| (C) Weighted average number of common shares outstanding, assuming dilution | 78.3 | 81.0 | 78.9 | 81.0 |
| Net income per common share: (A) ÷ (B) | $2.42 | $2.19 | $4.51 | $4.34 |
| Net income per common share, assuming dilution: (A) ÷ (C) | $2.41 | $2.18 | $4.50 | $4.31 |

---

Certain stock-based compensation awards were excluded from the computation of net income per common share, assuming dilution, because they would not have had a dilutive effect. Stock-based compensation awards excluded from the computation totaled 0.1 million shares for the three months ended June 28, 2025 and June 29, 2024. Stock-based compensation awards excluded from the computation totaled 0.2 million shares for the six months ended June 28, 2025 and 0.1 million shares for the six months ended June 29, 2024.

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

**Note 8. Supplemental Equity and Comprehensive Income Information** 

***Consolidated Changes in Shareholders' Equity***

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|<br>(In millions) | **June 28, 2025** | **June 29, 2024** | **June 28, 2025** | **June 29, 2024** |
| **Common stock issued, $1 par value per share** | $124.1 | $124.1 | $124.1 | $124.1 |
| **Capital in excess of par value** |  |  |  |  |
| Beginning balance | $817.7 | $834.0 | $840.6 | $854.5 |
| Issuance of shares under stock-based compensation plans<sup>(1)</sup> | 4.2 | (.9) | (18.7) | (21.4) |
| Ending balance | $821.9 | $833.1 | $821.9 | $833.1 |
| **Retained earnings** |  |  |  |  |
| Beginning balance | $5276.5 | $4809.1 | $5151.2 | $4691.8 |
| Cumulative-effect adjustment upon adoption of accounting standard update<sup>(2)</sup> |  |  | 10.2 |  |
| Net income | 189.0 | 176.8 | 355.3 | 349.2 |
| Issuance of shares under stock-based compensation plans<sup>(1)</sup> | 1.5 | .9 | 12.7 | 4.1 |
| Contribution of shares to 401(k) plan<sup>(1)</sup> | 5.8 | 6.3 | 12.8 | 13.3 |
| Dividends | (73.5) | (70.9) | (142.9) | (136.2) |
| Ending balance | $5399.3 | $4922.2 | $5399.3 | $4922.2 |
| **Treasury stock at cost** |  |  |  |  |
| Beginning balance | $(3598.6) | $(3141.2) | $(3347.5) | $(3134.4) |
| Repurchase of shares for treasury | (98.4) | (25.1) | (360.0) | (40.7) |
| Issuance of shares under stock-based compensation plans<sup>(1)</sup> | .6 | 9.8 | 8.3 | 16.3 |
| Contribution of shares to 401(k) plan<sup>(1)</sup> | 2.7 | 1.9 | 5.5 | 4.2 |
| Ending balance | $(3693.7) | $(3154.6) | $(3693.7) | $(3154.6) |
| **Accumulated other comprehensive loss** |  |  |  |  |
| Beginning balance | $(449.2) | $(422.0) | $(456.1) | $(408.1) |
| Other comprehensive income (loss), net of tax | (.8) | (15.7) | 6.1 | (29.6) |
| Ending balance | $(450.0) | $(437.7) | $(450.0) | $(437.7) |

---

<sup>(1)</sup> We fund a portion of our employee-related costs using shares of our common stock held in treasury. We reduce capital in excess of par value based on the grant date fair value of vesting awards and record net gains or losses associated with using treasury shares to retained earnings.

<sup>(2)</sup> In the first quarter of 2025, we adopted an accounting guidance update that requires crypto assets to be measured at fair value. This adjustment reflected the difference between the carrying value of our holdings in crypto assets and their fair value as of the beginning of 2025. Crypto assets were not material to the unaudited Condensed Consolidated Financial Statements.

Dividends per common share were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **June 28, 2025** | **June 29, 2024** | **June 28, 2025** | **June 29, 2024** |
| Dividends per common share | $.94 | $.88 | $1.82 | $1.69 |

---

In April 2025, our Board authorized the repurchase of shares of our common stock with a fair market value of up to $750 million, excluding any fees, commissions or other expenses related to such purchases and in addition to the amount outstanding under our previous Board authorization. Board authorizations remain in effect until shares in the amount authorized thereunder have been repurchased.

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

***Changes in Accumulated Other Comprehensive Loss***

The changes in "Accumulated other comprehensive loss" (net of tax) for the six-month period ended June 28, 2025 were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| (In millions) | **Foreign**<br>**Currency**<br>**Translation**<sup>(1)</sup> | **Pension and**<br>**Other**<br>**Postretirement**<br>**Benefits** | **Cash Flow**<br>**Hedges**  | **Fair Value**<br>**Hedges**  | **Total** |
| Balance as of December 28, 2024 | $(375.5) | $(78.0) | $(4.6) | $2.0 | $(456.1) |
| Other comprehensive income (loss) before reclassifications, net of tax | 2.4 |  | 1.4 | (1.1) | 2.7 |
| Reclassifications to net income, net of tax |  | 1.1 | 2.3 |  | 3.4 |
| Other comprehensive income (loss), net of tax | 2.4 | 1.1 | 3.7 | (1.1) | 6.1 |
| Balance as of June 28, 2025 | $(373.1) | $(76.9) | $(.9) | $.9 | $(450.0) |

---

<sup>(1)</sup> Included the impact of our foreign currency forward contracts and zero-cost collars, accounted for as net investment hedges. Refer to Note 5, "Financial Instruments," to the unaudited Condensed Consolidated Financial Statements for more information.

The changes in "Accumulated other comprehensive loss" (net of tax) for the six-month period ended June 29, 2024 were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| (In millions) | **Foreign**<br>**Currency**<br>**Translation** | **Pension and**<br>**Other**<br>**Postretirement**<br>**Benefits** | **Cash Flow**<br>**Hedges** | **Total** |
| Balance as of December 30, 2023 | $(328.6) | $(77.5) | $(2.0) | $(408.1) |
| Other comprehensive income (loss) before reclassifications, net of tax | (29.7) |  | (.6) | (30.3) |
| Reclassifications to net income, net of tax |  | .4 | .3 | .7 |
| Other comprehensive income (loss), net of tax | (29.7) | .4 | (.3) | (29.6) |
| Balance as of June 29, 2024 | $(358.3) | $(77.1) | $(2.3) | $(437.7) |

---

**Note 9. Fair Value Measurements** 

***Recurring Fair Value Measurements***

Assets and liabilities carried at fair value, measured on a recurring basis, as of June 28, 2025 were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | **Fair Value Measurements Using** | **Fair Value Measurements Using** | **Fair Value Measurements Using** |
|<br>(In millions) |<br>**Total** | **Quoted**<br>**Prices**<br>**in Active**<br>**Markets**<br>**(Level 1)** | **Significant**<br>**Other**<br>**Observable**<br>**Inputs**<br>**(Level 2)** | **Significant<br>Other<br>Unobservable<br>Inputs<br>(Level 3)** |
| **Assets** |  |  |  |  |
| &nbsp;&nbsp;Investments | $53.6 | $28.5 | $25.1 | $— |
| &nbsp;&nbsp;Derivative assets | 44.1 | .8 | 43.3 |  |
| &nbsp;&nbsp;Bank drafts | 5.8 | 5.8 |  |  |
| **Liabilities** |  |  |  |  |
| &nbsp;&nbsp;Derivative liabilities | $43.1 | $1.6 | $41.5 | $— |
| &nbsp;&nbsp;Contingent consideration liabilities | 4.5 |  |  | 4.5 |

---

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

Assets and liabilities carried at fair value, measured on a recurring basis, as of December 28, 2024 were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | **Fair Value Measurements Using** | **Fair Value Measurements Using** | **Fair Value Measurements Using** |
|<br>(In millions) |<br>**Total** | **Quoted**<br>**Prices**<br>**in Active**<br>**Markets**<br>**(Level 1)** | **Significant**<br>**Other**<br>**Observable**<br>**Inputs**<br>**(Level 2)** | **Significant**<br>**Other**<br>**Unobservable**<br>**Inputs**<br>**(Level 3)** |
| **Assets** |  |  |  |  |
| &nbsp;&nbsp;Investments | $48.0 | $24.2 | $23.8 | $— |
| &nbsp;&nbsp;Derivative assets | 41.2 | .4 | 40.8 |  |
| &nbsp;&nbsp;Bank drafts | 5.2 | 5.2 |  |  |
| **Liabilities** |  |  |  |  |
| &nbsp;&nbsp;Derivative liabilities | $41.5 | $.4 | $41.1 | $— |
| &nbsp;&nbsp;Contingent consideration liabilities | 4.8 |  |  | 4.8 |

---

Investments include fixed income securities (primarily U.S. government and corporate debt and equity securities) measured at fair value using quoted prices/bids and a money market fund measured at fair value using net asset value. As of June 28, 2025, investments of $6.4 million, $39.8 million and $7.4 million were included in "Cash and cash equivalents," "Other current assets" and "Other assets," respectively, in the unaudited Condensed Consolidated Balance Sheets. As of December 28, 2024, investments of $1.5 million, $38.1 million and $8.4 million were included in "Cash and cash equivalents," "Other current assets" and "Other assets," respectively, in the unaudited Condensed Consolidated Balance Sheets. Derivatives that are exchange-traded are measured at fair value using quoted market prices and classified within Level 1 of the valuation hierarchy. Derivatives measured based on foreign currency exchange rate inputs that are readily available in public markets are classified within Level 2 of the valuation hierarchy. Bank drafts (maturities greater than three months), which are valued at face value due to their short-term nature, were included in "Other current assets" in the unaudited Condensed Consolidated Balance Sheets.

Contingent consideration liabilities as of June 28, 2025 and December 28, 2024 relate to estimated earn-out payments associated with an acquisition completed in 2021, which are subject to the acquired company achieving certain post-acquisition performance targets. These liabilities were recorded based on the expected payments and have been classified within Level 3 of the valuation hierarchy. Activity related to contingent consideration was immaterial for the six months ended June 28, 2025 and June 29, 2024.

In addition to the investments described above, we hold venture investments that had a total carrying value of approximately $55 million and $45 million as of June 28, 2025 and December 28, 2024, respectively, which was included in "Other assets" in the unaudited Condensed Consolidated Balance Sheets. Starting in the second quarter of 2024, we began revaluing certain venture investments based on Level 1 inputs; the fair value of these investments was $7.4 million and $8.4 million as of June 28, 2025 and December 28, 2024, respectively. We recognized net losses of $1.8 million and $16.1 million, and $15.0 million and $17.2 million, in our venture and other investments for the three and six months ended June 28, 2025, and June 29, 2024, respectively. These net gains or losses were recorded in "Other expense (income), net" in the unaudited Condensed Consolidated Statements of Income.

**Note 10. Commitments and Contingencies** 

***Legal Proceedings***

We are involved in various lawsuits, claims, inquiries and other regulatory and compliance matters, most of which are routine to the nature of our business. When it is probable that a loss will be incurred and where a range of the loss can be reasonably estimated, the best estimate within the range is accrued. When the best estimate within the range cannot be determined, the low end of the range is accrued. The ultimate resolution of these claims could affect future results of operations should our exposure be materially different from our estimates or should we incur liabilities that were not previously accrued. Probable insurance reimbursements are not offset against potential liabilities.

Because of the uncertainties associated with claims resolution and litigation, future expenses to resolve legal proceedings could be higher than the liabilities we have accrued. If information were to become available that allowed us to reasonably estimate an amount higher or lower than what we have accrued in the range of potential expenses determine to be probable, we would adjust our accrued liabilities accordingly. Additional lawsuits, claims, inquiries and other regulatory and compliance matters could arise in the future. The range of expenses for resolving any future matters would be assessed as they arise; until then, a range of potential expenses for their resolution cannot be determined. Based upon current information, we believe that the impact of the resolution of legal proceedings would not be, individually or in the aggregate, material to our financial position, results of operations or cash flows.

***Environmental Expenditures***

Environmental expenditures are generally expensed. When it is probable that a loss will be incurred and where a range of the loss can be reasonably estimated, the best estimate within the range is accrued. When the best estimate within the range cannot be determined, the low end of the range is accrued. The ultimate resolution of these matters could affect future results of operations should our exposure be materially different from our estimates or should we incur liabilities that were not previously accrued. Probable insurance

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

reimbursements are not offset against potential liabilities. We review our estimates of the costs of complying with environmental laws related to the remediation and cleanup of various sites, including sites in which governmental agencies have designated us as a potentially responsible party ("PRP"). However, environmental expenditures for newly acquired assets and those that extend or improve the economic useful life of existing assets are capitalized and amortized over the shorter of the estimated useful life of the acquired asset or the remaining life of the existing asset.

As of June 28, 2025, we have been designated by the U.S. Environmental Protection Agency ("EPA") and/or other responsible state agencies as a PRP at ten waste disposal or waste recycling sites that are the subject of separate investigations or proceedings concerning alleged soil and/or groundwater contamination. No settlement of our liability related to any of these sites has been agreed upon. We are participating with other PRPs at these sites and anticipate that our share of remediation costs will be determined pursuant to agreements that we enter into with the EPA or other governmental authorities.

These estimates could change as a result of changes in planned remedial actions, remediation technologies, site conditions, the estimated time to complete remediation, environmental laws and regulations, and other factors. Because of the uncertainties associated with environmental assessment and remediation activities, our future expenses to remediate these sites could be higher than the liabilities we have accrued. If information were to become available that allowed us to reasonably estimate an amount higher or lower than what we have accrued in the range of potential expenses, we would adjust our environmental liabilities accordingly. In addition, we may be identified as a PRP at additional sites in the future. The range of expenses for remediation of any future-identified sites would be addressed as they arise; until then, a range of expenses for their remediation cannot be determined.

The activity related to our environmental liabilities for the six months ended June 28, 2025 is shown below.

---

| | |
|:---|:---|
| (In millions) |  |
| Balance at December 28, 2024 | $13.0 |
| Charges, net of reversals | .7 |
| Payments | (1.4) |
| Balance at June 28, 2025 | $12.3 |

---

Approximately $5 million of this balance was classified as short-term and included in "Other current liabilities" in the unaudited Condensed Consolidated Balance Sheets as of both June 28, 2025 and December 28, 2024.

**Note 11. Segment and Disaggregated Revenue Information** 

***Disaggregated Revenue Information***

Disaggregated revenue information is shown below in the manner that best reflects how the nature, amount, timing and uncertainty of our revenue and cash flows are affected by economic factors. Revenue from our Materials Group reportable segment is attributed to geographic areas based on the location from which products are shipped. Revenue from our Solutions Group reportable segment is shown by product group.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|<br>(In millions) | **June 28, 2025**<sup>(2)</sup> | **June 29, 2024** | **June 28, 2025**<sup>(2)</sup> | **June 29, 2024** |
| **Net sales to unaffiliated customers**<sup>(1)</sup> |  |  |  |  |
| Materials Group: |  |  |  |  |
| &nbsp;&nbsp;North America | $496.3 | $483.2 | $986.5 | $960.3 |
| &nbsp;&nbsp;Europe, the Middle East and North Africa | 548.3 | 549.9 | 1065.9 | 1084.6 |
| &nbsp;&nbsp;Asia Pacific | 385.6 | 386.7 | 744.1 | 750.8 |
| &nbsp;&nbsp;Latin America | 120.0 | 127.0 | 233.8 | 247.6 |
| Total Materials Group | 1550.2 | 1546.8 | 3030.3 | 3043.3 |
| Solutions Group: |  |  |  |  |
| &nbsp;&nbsp;Apparel and other | 431.6 | 476.5 | 886.4 | 936.4 |
| &nbsp;&nbsp;Identification Solutions and Vestcom | 238.7 | 212.0 | 452.1 | 406.9 |
| Total Solutions Group | 670.3 | 688.5 | 1338.5 | 1343.3 |
| Net sales to unaffiliated customers | $2220.5 | $2235.3 | $4368.8 | $4386.6 |

---

<sup>(1)</sup> Certain prior-period amounts have been reclassified to conform to the current-year presentation.

<sup>(2)</sup> Beginning in the first quarter of 2025 and to better align with our growth strategy, revenues for certain radio-frequency identification products were reflected in the Materials Group reportable segment; in prior years, these revenues were reflected in the Solutions Group reportable segment. Prior-year amounts were not material.

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

***Segment Information***

During the fourth quarter of 2024, we modified our segment performance measure to exclude other expense (income), net. These changes align with how our chief operating decision maker evaluates segment performance and allocates resources. Prior-year periods have been conformed to the current period presentation. Segment adjusted operating income is defined as income before taxes adjusted for other expense (income), net; interest expense; other non-operating expense (income), net; and other items. Segment results and reconciliation to income before taxes are presented below.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|<br>(In millions) | **June 28, 2025** | **June 29, 2024** | **June 28, 2025** | **June 29, 2024** |
| **Materials Group** |  |  |  |  |
| Net sales to unaffiliated customers | $1550.2 | $1546.8 | $3030.3 | $3043.3 |
| Segment expense<sup>(1)</sup> | 1307.7 | 1302.3 | 2557.5 | 2558.3 |
| Segment adjusted operating income | $242.5 | $244.5 | $472.8 | $485.0 |
| **Solutions Group** |  |  |  |  |
| Net sales to unaffiliated customers | $670.3 | $688.5 | $1338.5 | $1343.3 |
| Segment expense<sup>(1)</sup> | 603.3 | 618.7 | 1203.3 | 1212.6 |
| Segment adjusted operating income | $67.0 | $69.8 | $135.2 | $130.7 |

---

<sup>(1)</sup> Segment expense included cost of products sold and marketing, general and administrative expense and excluded other expense (income), net, and other items.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|<br>(In millions) | **June 28, 2025** | **June 29, 2024** | **June 28, 2025** | **June 29, 2024** |
| **Segment adjusted operating income** |  |  |  |  |
| Materials Group | $242.5 | $244.5 | $472.8 | $485.0 |
| Solutions Group | 67.0 | 69.8 | 135.2 | 130.7 |
| Total | 309.5 | 314.3 | 608.0 | 615.7 |
| Corporate expense | (22.8) | (25.5) | (46.8) | (53.2) |
| Other expense (income), net and other items | (.5) | (27.0) | (20.4) | (46.3) |
| Interest expense | (34.0) | (29.2) | (64.9) | (57.8) |
| Other non-operating expense (income), net | 3.3 | 5.8 | 6.6 | 14.4 |
| Income before taxes | $255.5 | $238.4 | $482.5 | $472.8 |

---

***Additional Segment Information***

Additional financial information by reportable segment is shown below.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|<br>(In millions) | **June 28, 2025** | **June 29, 2024** | **June 28, 2025** | **June 29, 2024** |
| **Intersegment sales** |  |  |  |  |
| Materials Group | $46.0 | $38.3 | $89.9 | $85.3 |
| Solutions Group | 12.5 | 15.4 | 25.7 | 26.3 |
| Intersegment sales | $58.5 | $53.7 | $115.6 | $111.6 |
| **Capital expenditures**<sup>(1)(2)</sup> |  |  |  |  |
| Materials Group | $18.4 | $21.2 | $32.0 | $41.7 |
| Solutions Group | 17.6 | 32.2 | 35.0 | 53.2 |
| Capital expenditures | $36.0 | $53.4 | $67.0 | $94.9 |
| **Depreciation and amortization expense**<sup>(1)</sup> |  |  |  |  |
| Materials Group | $33.0 | $32.8 | $64.5 | $65.6 |
| Solutions Group | 47.8 | 45.8 | 94.2 | 90.3 |
| Depreciation and amortization expense | $80.8 | $78.6 | $158.7 | $155.9 |

---

<sup>(1)</sup> Corporate capital expenditures and depreciation and amortization expense are allocated to our reportable segments based on their percentage of consolidated net sales.

<sup>(2)</sup> Capital expenditures for property, plant and equipment included accruals.

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

Other expense (income), net, by type was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|<br>(In millions) | **June 28, 2025** | **June 29, 2024** | **June 28, 2025** | **June 29, 2024** |
| **Other expense (income), net, by type** |  |  |  |  |
| Restructuring charges, net of reversals: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Severance and related costs, net of reversals | $7.9 | $6.3 | $12.6 | $11.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Asset impairment and lease cancellation charges | .1 | .9 | .3 | 2.0 |
| Other items: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;(Gain) loss on venture and other investments | 1.8 | 15.0 | 16.1 | 17.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Losses from Argentine peso remeasurement and Blue Chip Swap transactions | 1.8 | 4.1 | 2.5 | 15.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;(Gain) loss on sales of assets | (11.1) |  | (11.1) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Outcomes of legal matters and settlements, net |  | .4 |  | (6.5) |
| &nbsp;&nbsp;&nbsp;&nbsp;Transaction and related costs |  | .3 |  | .3 |
| Other expense (income), net | $.5 | $27.0 | $20.4 | $39.6 |

---

**Note 12. Supplemental Financial Information** 

***Inventories***

The table below summarizes amounts in inventories.

---

| | | |
|:---|:---|:---|
| (In millions) | **June 28, 2025** | **December 28, 2024** |
| Raw materials | $426.3 | $435.0 |
| Work-in-progress | 246.6 | 224.9 |
| Finished goods | 354.0 | 318.2 |
| Inventories | $1026.9 | $978.1 |

---

***Property, Plant and Equipment, Net***

The table below summarizes the amounts in property, plant and equipment, net.

---

| | | |
|:---|:---|:---|
| (In millions) | **June 28, 2025** | **December 28, 2024** |
| Property, plant and equipment | $4191.7 | $3993.5 |
| Accumulated depreciation | (2587.5) | (2406.8) |
| Property, plant and equipment, net | $1604.2 | $1586.7 |

---

***Allowance for Credit Losses***

The activity related to our allowance for credit losses is shown below.

---

| | | |
|:---|:---|:---|
| | **Six Months Ended** | **Six Months Ended** |
|<br>(In millions) | **June 28, 2025** | **June 29, 2024** |
| Beginning balance | $29.0 | $34.4 |
| Provision for credit losses | 2.1 | 5.8 |
| Amounts written off | (2.6) | (2.7) |
| Other, including foreign currency translation | 1.7 | (.8) |
| Ending balance | $30.2 | $36.7 |

---

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

***Supplier Finance Programs***

We have agreements with third-party financial institutions to facilitate payments to suppliers. These third-party financial institutions offer voluntary supply chain finance programs that enable certain of our suppliers, at the supplier's sole discretion, to sell our payment obligations to a financial institution on terms directly negotiated with the financial institution. Participating suppliers decide which payment obligations are sold to the financial institution and we have no economic interest in a supplier's decision to sell these payment obligations. We make payments to the financial institution on the invoice due date, regardless of whether an individual invoice is sold by the supplier to the financial institution. Our obligations to our suppliers, including amounts due and scheduled payment dates, are not impacted by suppliers' decisions to sell amounts under these arrangements. Amounts due under our supply chain finance programs were included in accounts payable in our unaudited Condensed Consolidated Balance Sheets and activities related to these programs were presented as operating activities in our unaudited Condensed Consolidated Statements of Cash Flows. As of June 28, 2025 and December 28, 2024, the amounts due to financial institutions for suppliers that participate in these programs were $404.2 million and $384.6 million, respectively.

***Argentine Blue Chip Swap***

During 2019, the Argentine government instituted exchange controls restricting the ability of entities and individuals to exchange Argentine pesos for foreign currencies or remit foreign currency out of Argentina. Due to these currency exchange restrictions, markets in Argentina use a legal trading mechanism known as the Blue Chip Swap that allows entities to transfer U.S. dollars in and out of Argentina. During the three and six months ended June 29, 2024, we entered into Blue Chip Swap transactions that resulted in losses of approximately $4 million and $10 million, respectively, that we recorded in "Other expense (income), net" in the unaudited Condensed Consolidated Statements of Income. Purchases and the proceeds from sales of Argentine Blue Chip Swap securities were included in investing activities in our unaudited Condensed Consolidated Statements of Cash Flows.

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

**ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS** 

Management's Discussion and Analysis of Financial Condition and Results of Operations, or MD&A, should be read in conjunction with the accompanying unaudited Condensed Consolidated Financial Statements and related notes thereto.

**<u>NON-GAAP FINANCIAL MEASURES</u>**

We report our financial results in conformity with accounting principles generally accepted in the United States of America, or GAAP, and also communicate with investors using certain non-GAAP financial measures. These non-GAAP financial measures are not in accordance with, nor are they a substitute for or superior to, the comparable GAAP financial measures. These non-GAAP financial measures are intended to supplement the presentation of our financial results prepared in accordance with GAAP. We use these non-GAAP financial measures internally to evaluate trends in our underlying performance, as well as to facilitate comparisons with the results of competitors for quarters and year-to-date periods, as applicable. Based on feedback from investors and financial analysts, we believe that the supplemental non-GAAP financial measures we provide are also useful to their assessments of our performance and operating trends, as well as liquidity. Reconciliations of our non-GAAP financial measures from the most directly comparable GAAP financial measures are provided in accordance with Regulations G and S-K.

Our non-GAAP financial measures exclude the impact of certain events, activities or strategic decisions. The accounting effects of these events, activities or decisions, which are included in the GAAP financial measures, may make it more difficult to assess our underlying performance in a single period. By excluding the accounting effects, positive or negative, of certain items (e.g., restructuring charges, outcomes of certain legal matters and settlements, certain effects of strategic transactions and related costs, losses from debt extinguishments, gains or losses from curtailment or settlement of pension obligations, gains or losses on sales of certain assets, gains or losses on venture and other investments, currency adjustments due to highly inflationary economies, and other items), we believe that we are providing meaningful supplemental information that facilitates an understanding of our core operating results and liquidity measures. While some of the items we exclude from GAAP financial measures recur, they tend to be disparate in amount, frequency or timing.

We use the non-GAAP financial measures defined below in this MD&A.

• *Sales change ex. currency* refers to the increase or decrease in net sales, excluding the estimated impact of foreign currency translation, and, where applicable, the currency adjustments for transitional reporting of highly inflationary economies and the reclassification of sales between segments. Additionally, where applicable, sales change ex. currency is also adjusted for an extra week in our fiscal year and the calendar shift resulting from an extra week in the prior fiscal year. The estimated impact of foreign currency translation is calculated on a constant currency basis, with prior-period results translated at current period average exchange rates to exclude the effect of foreign currency fluctuations. Our 2025 fiscal year that began on December 29, 2024 will end on December 31, 2025; fiscal years 2026 and beyond will be coincident with the calendar year beginning on January 1 and ending on December 31.

• *Organic sales change* refers to sales change ex. currency, excluding the estimated impact of acquisitions and product line divestitures.

We believe that sales change ex. currency and organic sales change assist investors in evaluating the sales change from the ongoing activities of our businesses and enhance their ability to evaluate our results from period to period.

• *Adjusted free cash flow* refers to cash flow provided by operating activities, less payments for property, plant and equipment, less payments for software and other deferred charges, plus proceeds from company-owned life insurance policies, plus proceeds from sales of property, plant and equipment, plus (minus) net proceeds from insurance and sales (purchases) of investments, less net cash used for Argentine Blue Chip Swap securities. Where applicable, adjusted free cash flow is also adjusted for certain acquisition-related transaction costs. We believe that adjusted free cash flow assists investors by showing the amount of cash we have available for debt reductions, dividends, share repurchases and acquisitions.

• *Operational working capital as a percentage of annualized current quarter net sales* refers to trade accounts receivable and inventories, net of accounts payable, and excludes cash and cash equivalents, short-term borrowings, deferred taxes, other current assets and other current liabilities divided by annualized current quarter net sales. We believe that operational working capital as a percentage of annualized current quarter net sales assists investors in assessing our working capital requirements because it excludes the impact of fluctuations attributable to our financing and other activities (which affect cash and cash equivalents, deferred taxes, other current assets and other current liabilities) that tend to be disparate in amount, frequency or timing, and may increase the volatility of working capital as a percentage of sales from period to period. The items excluded from this measure are not significantly influenced by our day-to-day activities managed at the operating level and do not necessarily reflect the underlying trends in our operations.

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

**<u>OVERVIEW AND OUTLOOK</u>**

**Fiscal Year**

In January 2025, the Audit Committee of our Board of Directors approved a change to our previous 52- or 53-week fiscal year generally ending on the Saturday closest to December 31 to a fiscal year coincident with the calendar year. Our 2025 fiscal year that began on December 29, 2024 will end on December 31, 2025 and fiscal years 2026 and beyond will begin on January 1 and end on December 31.

**Net Sales** 

The factors impacting reported net sales change, as compared to the prior-year period, are shown in the table below.

---

| | | |
|:---|:---|:---|
| | **Three Months Ended** <br>**June 28, 2025** | **Six Months Ended** <br>**June 28, 2025** |
| Reported net sales change | (1)% | —% |
| &nbsp;&nbsp;Foreign currency translation |  | 1 |
| Sales change ex. currency<sup>(1)</sup> | (1) | 1 |
| Organic sales change<sup>(1)</sup> | (1)% | 1% |

---

<sup>(1)</sup> Totals may not sum due to rounding.

In the three months ended June 28, 2025, net sales decreased on an organic basis compared to the same period in the prior year primarily due to the impact of raw material deflation-related price reductions, partially offset by higher volume/mix. In the six months ended June 28, 2025, net sales increased on an organic basis compared to the same period in the prior year primarily due to higher volume/mix, partially offset by the impact of raw material deflation-related price reductions.

**Net Income** 

Net income increased from approximately $349 million in the first six months of 2024 to approximately $355 million in the first six months of 2025. The primary factors affecting this increase were:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Benefits from productivity initiatives, including material re-engineering and savings from restructuring actions, net of transition costs

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Higher volume/mix

These items were partially offset by the net impact of raw material deflation-related price reductions.

**Cost Reduction Actions** 

*2025 Actions*

We recorded $12.9 million in restructuring charges, net of reversals, during the six months ended June 28, 2025. These charges consisted of severance and related costs for the reduction of approximately 460 positions, as well as asset impairment charges, at various locations across our company. Our 2025 actions are primarily intended to optimize our operational footprint.

Restructuring charges were included in "Other expense (income), net" in the unaudited Condensed Consolidated Statements of Income. Refer to Note 4, "Cost Reduction Actions," to the unaudited Condensed Consolidated Financial Statements for more information.

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

**Cash Flow** 

---

| | | |
|:---|:---|:---|
| | **Six Months Ended** | **Six Months Ended** |
| (In millions) | **June 28, 2025** | **June 29, 2024** |
| Net cash provided by operating activities | $192.5 | $317.5 |
| Purchases of property, plant and equipment | (66.0) | (96.3) |
| Purchases of software and other deferred charges | (15.2) | (12.9) |
| Purchases of Argentine Blue Chip Swap securities |  | (34.2) |
| Proceeds from sales of Argentine Blue Chip Swap securities |  | 24.0 |
| Proceeds from sales of property, plant and equipment | 15.7 | .3 |
| Proceeds from insurance and sales (purchases) of investments, net | 8.8 | 2.2 |
| Adjusted free cash flow | $135.8 | $200.6 |

---

During the first six months of 2025, net cash provided by operating activities decreased compared to the same period last year primarily due to higher incentive compensation payments, changes in operational working capital, higher trade rebate payments, and tax payments, net of refunds, partially offset by the prior-year settlement payment for the Adasa legal matter. During the first six months of 2025, adjusted free cash flow decreased compared to the same period last year primarily due to a decrease in net cash provided by operating activities, partially offset by lower purchases of property, plant and equipment and higher proceeds from the sales of property, plant and equipment.

**Outlook** 

Beginning in the first quarter of 2025, the U.S. announced tariffs on goods imported into the U.S. from numerous countries, many of which responded with reciprocal tariffs and other actions on goods imported from the U.S. The U.S. government continues to negotiate with other countries regarding the tariffs; to enable these negotiations, it paused certain of these tariffs until August 1, 2025. As it relates to the direct impact of these tariffs, a relatively small portion of our global materials purchases is impacted and the vast majority of our imports and exports between the U.S., Canada and Mexico are compliant with the United States-Mexico-Canada Agreement ("USMCA"). Based on current information, we estimate that the overall direct impact will likely increase our total raw material costs by a low single digit rate. To mitigate the direct impact to our operations, we have implemented strategic sourcing adjustments and pricing surcharges. The indirect impact on demand for our products and solutions is more uncertain. While a majority of our products and solutions relates to less discretionary consumer staples, we also serve more discretionary and cyclical markets, such as industrials, durables and apparel. In the second quarter of 2025, we estimated that the indirect impact on apparel end markets resulted in a mid-single digit rate decrease in our sales in overall apparel categories.

Certain factors that we believe may contribute to or impact our 2025 results are described below.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We anticipate elevated uncertainty related to trade policy and the macroeconomic environment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In the third quarter of 2025, we anticipate a sequential decrease in operating income due to volume seasonality.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• For the full year:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ We expect a favorable impact to our net sales and operating income from foreign currency translation, based on recent rates.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ We anticipate incremental savings from restructuring actions, net of transition costs.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ We expect our effective tax rate to be in the mid-twenty percent range.

**<u>ANALYSIS OF RESULTS OF OPERATIONS FOR THE SECOND QUARTER</u>**

**Income Before Taxes** 

---

| | | |
|:---|:---|:---|
| | **Three Months Ended**  | **Three Months Ended**  |
| (In millions) | **June 28, 2025** | **June 29, 2024** |
| Net sales | $2220.5 | $2235.3 |
| Cost of products sold | 1581.4 | 1572.6 |
| Gross profit | 639.1 | 662.7 |
| Marketing, general and administrative expense | 352.4 | 373.9 |
| Other expense (income), net | .5 | 27.0 |
| Interest expense | 34.0 | 29.2 |
| Other non-operating expense (income), net | (3.3) | (5.8) |
| Income before taxes | $255.5 | $238.4 |

---

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

*Gross Profit* 

Gross profit for the second quarter of 2025 decreased from the same period last year due to the net impact of raw material deflation-related price reductions and higher employee-related costs, partially offset by higher volume/mix and benefits from productivity initiatives, including material re-engineering and savings from restructuring actions, net of transition costs.

*Marketing, General and Administrative Expense* 

Marketing, general and administrative expense decreased in the second quarter of 2025 compared to the same period last year primarily due to lower employee-related costs and benefits from productivity initiatives, including savings from restructuring actions, net of transition costs.

*Other Expense (Income), Net* 

---

| | | |
|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** |
| (In millions) | **June 28, 2025** | **June 29, 2024** |
| **Other expense (income), net, by type** |  |  |
| Restructuring charges, net of reversals: |  |  |
| &nbsp;&nbsp;Severance and related costs, net of reversals | $7.9 | $6.3 |
| &nbsp;&nbsp;Asset impairment and lease cancellation charges | .1 | .9 |
| Other items: |  |  |
| (Gain) loss on venture and other investments | 1.8 | 15.0 |
| &nbsp;&nbsp;Losses from Argentine peso remeasurement and Blue Chip Swap transactions | 1.8 | 4.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;(Gain) loss on sales of assets | (11.1) |  |
| &nbsp;&nbsp;Outcomes of legal matters and settlements, net |  | .4 |
| &nbsp;&nbsp;Transaction and related costs |  | .3 |
| Other expense (income), net | $.5 | $27.0 |

---

Refer to Note 4, "Cost Reduction Actions," to the unaudited Condensed Consolidated Financial Statements for more information regarding restructuring charges.

*Interest Expense* 

Interest expense increased in the second quarter of 2025 compared to the same period last year primarily due to higher interest related to the €500 million of senior notes we issued in November 2024 and an increase in commercial paper borrowings.

**Net Income and Earnings per Share** 

---

| | | |
|:---|:---|:---|
| | **Three Months Ended**  | **Three Months Ended**  |
| (In millions, except per share amounts and percentages) | **June 28, 2025** | **June 29, 2024** |
| Income before taxes | $255.5 | $238.4 |
| Provision for income taxes | 66.5 | 61.6 |
| Net income | $189.0 | $176.8 |
| Per share amounts: |  |  |
| Net income per common share | $2.42 | $2.19 |
| Net income per common share, assuming dilution | 2.41 | 2.18 |
| Effective tax rate | 26.0% | 25.8% |

---

*Provision for Income Taxes* 

Our effective tax rate for the three months ended June 28, 2025 was comparable to the same period last year. Refer to Note 6, "Taxes Based on Income," to the unaudited Condensed Consolidated Financial Statements for more information.

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

**<u>RESULTS OF OPERATIONS BY REPORTABLE SEGMENT FOR THE SECOND QUARTER</u>**

During the fourth quarter of 2024, we modified our segment performance measure to exclude other expense (income), net. These changes align with how our chief operating decision maker evaluates segment performance and allocates resources. Prior-year periods have been conformed to the current period presentation. Segment adjusted operating income is defined as income before taxes adjusted for other expense (income), net; interest expense; other non-operating expense (income), net; and other items.

Refer to Note 11, "Segment and Disaggregated Revenue Information," to the unaudited Condensed Consolidated Financial Statements for more information.

***Materials Group***

---

| | | |
|:---|:---|:---|
| | **Three Months Ended**  | **Three Months Ended**  |
| (In millions) | **June 28, 2025** | **June 29, 2024** |
| Net sales including intersegment sales | $1596.2 | $1585.1 |
| Less intersegment sales | (46.0) | (38.3) |
| Net sales | $1550.2 | $1546.8 |
| Segment adjusted operating income<sup>(1)</sup> | 242.5 | 244.5 |

---

<sup>(1)</sup> Segment adjusted operating income excluded other expense (income), net, and other items of $(7.0) million and $21.1 million in the second quarter of 2025 and 2024, respectively. Exclusions related to charges associated with restructuring actions, losses from Argentine peso remeasurement and Blue Chip Swap transactions, (gain) loss on venture and other investments, (gain) loss of sales of assets and outcomes of legal matters and settlements, net.

The factors impacting reported net sales change, as compared to the prior-year period, are shown in the table below.

---

| | |
|:---|:---|
| | **Three Months Ended** |
| | **June 28, 2025** |
| Reported net sales change | —% |
| &nbsp;&nbsp;Reclassification of sales between segments | (1) |
| &nbsp;&nbsp;Foreign currency translation | (1) |
| Sales change ex. currency<sup>(1)</sup> | (1) |
| Organic sales change<sup>(1)</sup> | (1)% |

---

<sup>(1)</sup> Totals may not sum due to rounding.

In the second quarter of 2025, net sales decreased on an organic basis compared to the same period in the prior year mainly due to the impact of raw material deflation-related price reductions, partially offset by favorable volume/mix. On an organic basis, net sales increased by a low single digit rate in North America, decreased by a mid-single digit rate in Europe, the Middle East and North Africa, were comparable in Asia Pacific and increased by a mid-single digit rate in Latin America.

*Segment Adjusted Operating Income* 

Segment adjusted operating income decreased in the second quarter of 2025 compared to the same period last year primarily due to the net impact of pricing and raw material input costs, partially offset by productivity initiatives, including material re-engineering and savings from restructuring actions, net of transition costs, and favorable volume/mix.

***Solutions Group***

---

| | | |
|:---|:---|:---|
| | **Three Months Ended**  | **Three Months Ended**  |
| (In millions) | **June 28, 2025** | **June 29, 2024** |
| Net sales including intersegment sales | $682.8 | $703.9 |
| Less intersegment sales | (12.5) | (15.4) |
| Net sales | $670.3 | $688.5 |
| Segment adjusted operating income<sup>(1)</sup> | 67.0 | 69.8 |

---

<sup>(1)</sup> Segment adjusted operating income excluded other expense (income), net, and other items of $7.2 million and $5.7 million in the second quarter of 2025 and 2024, respectively. Exclusions related to charges associated with restructuring actions, (gain) loss on venture and other investments and transaction and related costs.

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

*Net Sales* 

The factors impacting reported net sales change, as compared to the prior-year period, are shown in the table below.

---

| | |
|:---|:---|
| | **Three Months Ended** |
| | **June 28, 2025** |
| Reported net sales change | (3)% |
| &nbsp;&nbsp;Reclassification of sales between segments | 2 |
| &nbsp;&nbsp;Foreign currency translation |  |
| Sales change ex. currency<sup>(1)</sup> | (1) |
| Organic sales change<sup>(1)</sup> | (1)% |

---

<sup>(1)</sup> Totals may not sum due to rounding.

In the second quarter of 2025, net sales decreased on an organic basis compared to the same period in the prior year due to a low single digit rate increase in high-value categories, which was more than offset by a decrease of a mid-single digit rate in the base business. Company-wide, on an organic basis, net sales of intelligent labels were comparable to the same period in the prior year.

*Segment Adjusted Operating Income* 

Segment adjusted operating income decreased in the second quarter of 2025 compared to the same period last year primarily due to the net impact of pricing and raw material costs and growth investments, partially offset by benefits from productivity initiatives, including savings from restructuring actions, net of transition costs.

**<u>ANALYSIS OF RESULTS OF OPERATIONS FOR THE SIX MONTHS YEAR-TO-DATE</u>**

**Income Before Taxes** 

---

| | | |
|:---|:---|:---|
| | **Six Months Ended** | **Six Months Ended** |
| (In millions) | **June 28, 2025** | **June 29, 2024** |
| Net sales | $4368.8 | $4386.6 |
| Cost of products sold | 3108.2 | 3091.7 |
| Gross profit | 1260.6 | 1294.9 |
| Marketing, general and administrative expense | 699.4 | 739.1 |
| Other expense (income), net | 20.4 | 39.6 |
| Interest expense | 64.9 | 57.8 |
| Other non-operating expense (income), net | (6.6) | (14.4) |
| Income before taxes | $482.5 | $472.8 |

---

*Gross Profit* 

Gross profit for the first six months of 2025 decreased from the same period last year primarily due to the net impact of pricing and raw material input costs, higher employee-related costs and the impact of unfavorable foreign currency translation, partially offset by benefits from productivity initiatives, including material re-engineering and savings from restructuring actions, net of transition costs, and higher volume/mix.

*Marketing, General and Administrative Expense* 

Marketing, general and administrative expense decreased in the first six months of 2025 compared to the same period last year primarily due to lower employee-related costs and benefits from productivity initiatives, including temporary cost-saving actions and savings from restructuring actions, net of transition costs, partially offset by growth investments.

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

*Other Expense (Income), Net* 

---

| | | |
|:---|:---|:---|
| | **Six Months Ended** | **Six Months Ended** |
| (In millions) | **June 28, 2025** | **June 29, 2024** |
| **Other expense (income), net, by type** |  |  |
| Restructuring charges, net of reversals: |  |  |
| &nbsp;&nbsp;Severance and related costs, net of reversals | $12.6 | $11.2 |
| &nbsp;&nbsp;Asset impairment and lease cancellation charges | .3 | 2.0 |
| Other items: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;(Gain) loss on venture and other investments | 16.1 | 17.2 |
| &nbsp;&nbsp;Losses from Argentine peso remeasurement and Blue Chip Swap transactions | 2.5 | 15.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;(Gain) loss on sales of assets | (11.1) |  |
| &nbsp;&nbsp;Outcomes of legal matters and settlements, net |  | (6.5) |
| &nbsp;&nbsp;Transaction and related costs |  | .3 |
| Other expense (income), net | $20.4 | $39.6 |

---

Refer to Note 4, "Cost Reduction Actions," to the unaudited Condensed Consolidated Financial Statements for more information regarding restructuring charges.

*Interest Expense* 

Interest expense increased for the six months of 2025 compared to the same period last year primarily due to higher interest related to the €500 million of senior notes we issued in November 2024 and an increase in commercial paper borrowings.

**Net Income and Earnings per Share** 

---

| | | |
|:---|:---|:---|
| | **Six Months Ended** | **Six Months Ended** |
| (In millions, except per share amounts and percentages) | **June 28, 2025** | **June 29, 2024** |
| Income before taxes | $482.5 | $472.8 |
| Provision for income taxes | 127.2 | 123.6 |
| Net income | $355.3 | $349.2 |
| Per share amounts: |  |  |
| Net income per common share | $4.51 | $4.34 |
| Net income per common share, assuming dilution | 4.50 | 4.31 |
| Effective tax rate | 26.4% | 26.1% |

---

*Provision for Income Taxes* 

Our effective tax rate for the six months ended June 28, 2025 was comparable to the same period last year. Refer to Note 6, "Taxes Based on Income," to the unaudited Condensed Consolidated Financial Statements for more information.

**<u>RESULTS OF OPERATIONS BY REPORTABLE SEGMENT FOR THE SIX MONTHS YEAR-TO-DATE</u>**

***Materials Group***

---

| | | |
|:---|:---|:---|
| | **Six Months Ended** | **Six Months Ended** |
| (In millions) | **June 28, 2025** | **June 29, 2024** |
| Net sales including intersegment sales | $3120.2 | $3128.6 |
| Less intersegment sales | (89.9) | (85.3) |
| Net sales | $3030.3 | $3043.3 |
| Segment adjusted operating income<sup>(1)</sup> | 472.8 | 485.0 |

---

<sup>(1)</sup> Segment adjusted operating income excluded other expense (income), net, and other items of $(2.6) million and $35.5 million in the first six months of 2025 and 2024, respectively. Exclusions related to charges associated with restructuring actions, losses from Argentine peso remeasurement and Blue Chip Swap transactions, (gain) loss on venture and other investments, (gain) loss of sales of assets and outcomes of legal matters and settlements, net.

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

*Net Sales* 

The factors impacting reported net sales change, as compared to the prior-year period, are shown in the table below.

---

| | |
|:---|:---|
| | **Six Months Ended** |
| | **June 28, 2025** |
| Reported net sales change | —% |
| &nbsp;&nbsp;Reclassification of sales between segments | (1) |
| &nbsp;&nbsp;Foreign currency translation | 1 |
| Sales change ex. currency<sup>(1)</sup> |  |
| Organic sales change<sup>(1)</sup> | —% |

---

<sup>(1)</sup> Totals may not sum due to rounding

In the first six months of 2025, net sales were comparable on an organic basis compared to the same period in the prior year mainly due to higher volume/mix offsetting the impact of raw material deflation-related price reductions. On an organic basis, net sales increased by a low single digit rate in North America, decreased by a low single digit rate in Europe, the Middle East and North Africa, were comparable in Asia Pacific and increased by a mid-single digit rate in Latin America.

*Segment Adjusted Operating Income* 

Segment adjusted operating income decreased in the first six months of 2025 compared to the same period last year primarily due to the net impact of pricing and raw material input costs and the impact of unfavorable foreign currency translation, partially offset by benefits from productivity initiatives, including material re-engineering and savings from restructuring actions, net of transition costs, and higher volume/mix.

***Solutions Group***

---

| | | |
|:---|:---|:---|
| | **Six Months Ended** | **Six Months Ended** |
| (In millions) | **June 28, 2025** | **June 29, 2024** |
| Net sales including intersegment sales | $1364.2 | $1369.6 |
| Less intersegment sales | (25.7) | (26.3) |
| Net sales | $1338.5 | $1343.3 |
| Segment adjusted operating income<sup>(1)</sup> | 135.2 | 130.7 |

---

<sup>(1)</sup> Segment adjusted operating income excluded other expense (income), net, and other items of $17.3 million and $3.8 million in the first six months of 2025 and 2024, respectively. Exclusions related to charges associated with restructuring actions, (gain) loss on venture and other investments, transaction and related costs and outcomes of legal matters and settlements, net.

*Net Sales* 

The factors impacting reported net sales change, as compared to the prior-year period, are shown in the table below.

---

| | |
|:---|:---|
| | **Six Months Ended** |
| | **June 28, 2025** |
| Reported net sales change | —% |
| &nbsp;&nbsp;Reclassification of sales between segments | 2 |
| &nbsp;&nbsp;Foreign currency translation | 1 |
| Sales change ex. currency<sup>(1)</sup> | 2 |
| Organic sales change<sup>(1)</sup> | 2% |

---

<sup>(1)</sup> Totals may not sum due to rounding

In the first six months of 2025, net sales increased on an organic basis compared to the same period in the prior year due to low single digit rate increases in high-value categories and the base business. Company-wide, on an organic basis, net sales of intelligent labels increased by a low single digit rate compared to the same period in the prior year.

*Segment Adjusted Operating Income* 

Segment adjusted operating income increased in the first six months of 2025 compared to the same period last year primarily due to benefits from productivity initiatives, including savings from restructuring actions, net of transition costs, and higher volume, partially offset by the net impact of pricing and raw material costs and growth investments.

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

**<u>FINANCIAL CONDITION</u>**

**Liquidity** 

**Operating Activities** 

---

| | | |
|:---|:---|:---|
| | **Six Months Ended** | **Six Months Ended** |
|<br>(In millions) | **June 28, 2025** | **June 29, 2024** |
| Net income | $355.3 | $349.2 |
| Depreciation | 100.3 | 98.7 |
| Amortization | 58.4 | 57.2 |
| Provision for credit losses and sales returns | 25.3 | 28.2 |
| Stock-based compensation | 14.7 | 17.4 |
| Deferred taxes and other non-cash taxes | (12.0) | (3.8) |
| Other non-cash expense and loss (income and gain), net | 20.8 | 46.6 |
| Changes in assets and liabilities and other adjustments | (370.3) | (276.0) |
| Net cash provided by operating activities | $192.5 | $317.5 |

---

During the first six months of 2025, net cash provided by operating activities decreased compared to the same period last year primarily due to higher incentive compensation payments, changes in operational working capital, higher trade rebate payments, and tax payments, net of refunds, partially offset by the prior-year settlement payment for the Adasa legal matter.

**Investing Activities** 

---

| | | |
|:---|:---|:---|
| | **Six Months Ended** | **Six Months Ended** |
|<br>(In millions) | **June 28, 2025** | **June 29, 2024** |
| Purchases of property, plant and equipment | $(66.0) | $(96.3) |
| Purchases of software and other deferred charges | (15.2) | (12.9) |
| Purchases of Argentine Blue Chip Swap securities |  | (34.2) |
| Proceeds from sales of Argentine Blue Chip Swap securities |  | 24.0 |
| Proceeds from sales of property, plant and equipment | 15.7 | .3 |
| Proceeds from insurance and sales (purchases) of investments, net | 8.8 | 2.2 |
| Proceeds from settlement of net investment hedges | 6.2 |  |
| Payments for acquisitions, net of cash acquired, and venture investments | (10.7) | (1.9) |
| Net cash used in investing activities | $(61.2) | $(118.8) |

---

*Purchases of Property, Plant and Equipment* 

During the first six months of 2025, in our Materials Group reportable segment, we primarily invested in equipment to support growth in the U.S., certain countries in Europe and certain countries in Asia Pacific, primarily China; in our Solutions Group reportable segment, we primarily invested in buildings and equipment to support growth in certain countries in Asia Pacific, including Vietnam and China, and in the U.S. During the first six months of 2024, in our Solutions Group reportable segment, we primarily invested in buildings and equipment in certain countries in Asia Pacific, including China and Vietnam, in the U.S. and in certain countries in Latin America, primarily Mexico; in our Materials Group reportable segment, we primarily invested in buildings and equipment to support growth in the U.S. and certain countries in Europe, primarily France.

*Purchases of Software and Other Deferred Charges* 

During the first six months of 2025 and 2024, we primarily invested in information technology upgrades in the U.S.

*Purchases and Proceeds from Sales of Argentine Blue Chip Swap Securities*

During the first six months of 2024, we entered into Blue Chip Swap transactions that resulted in losses of approximately $10 million. Refer to Note 12, "Supplemental Financial Information," to the unaudited Condensed Consolidated Financial Statements for more information.

*Proceeds from Sales of Property, Plant and Equipment*

During the first six months of 2025, we received proceeds from the sale of property in China.

*Proceeds from Insurance and Sales (Purchases) of Investments, Net*

During the first six months of 2025, we received higher proceeds from sales from investments and insurance policies.

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

*Proceeds from Settlement of Net Investment Hedges*

During the first six months of 2025, we settled €420 million notional amount of net investment hedges.

*Payments for Acquisitions, Net of Cash Acquired, and Venture Investments*

During the first six months of 2025 and 2024, we made several venture investments.

**Financing Activities** 

---

| | | |
|:---|:---|:---|
| | **Six Months Ended** | **Six Months Ended** |
|<br>(In millions) | **June 28, 2025** | **June 29, 2024** |
| Net increase (decrease) in borrowings with maturities of three months or less | $816.2 | $(2.2) |
| Repayments of long-term debt and finance leases | (551.6) | (3.5) |
| Dividends paid | (142.9) | (136.2) |
| Share repurchases | (360.0) | (40.7) |
| Net (tax withholding) proceeds related to stock-based compensation | (12.6) | (18.4) |
| Payments for settlement of fair value hedges | (13.5) |  |
| Other | 15.9 | (1.1) |
| Net cash used in financing activities | $(248.5) | $(202.1) |

---

*Borrowings and Repayment of Debt* 

During the first six months of 2025 and 2024, our commercial paper borrowings were used to fund the repayment of long-term debt, dividend payments, share repurchases, capital expenditures and other general corporate purposes.

In the first quarter of 2025, we repaid our €500 million of senior notes at maturity using the net proceeds from the €500 million of senior notes we issued in the fourth quarter of 2024, cash flows from operations and commercial paper borrowings.

In the second quarter of 2025, we repaid our $25 million of medium-term notes at maturity using cash flows from operations and commercial paper borrowings.

Refer to Note 3, "Debt," to the unaudited Condensed Consolidated Financial Statements for more information.

*Dividends Paid* 

We paid dividends of $1.82 per share in the first six months of 2025 compared to $1.69 per share in the same period last year. In April 2025, we increased our quarterly dividend rate to $0.94 per share, representing an increase of approximately 7% from our previous quarterly dividend rate of $0.88 per share.

*Share Repurchases* 

During the first six months of 2025 and 2024, we repurchased approximately 2.0 million and 0.2 million shares of our common stock, respectively.

In April 2025, our Board authorized the repurchase of shares of our common stock with a fair market value of up to $750 million, excluding any fees, commissions or other expenses related to such purchases and in addition to the amount outstanding under our previous Board authorization. Board authorizations remain in effect until shares in the amount authorized thereunder have been repurchased.

*Net (Tax Withholding) Proceeds Related to Stock-based Compensation*

Tax withholding for stock-based compensation was lower in the first six months of 2025 compared to 2024 primarily due to a lower number of shares vesting for certain performance-based awards based on our performance against the objectives established for the awards.

*Payments for Settlement of Fair Value Hedges*

During the first six months of 2025, we settled €420 million notional amount of fair value hedges.

**Analysis of Selected Balance Sheet Accounts** 

*Long-lived Assets* 

In the six months ended June 28, 2025, goodwill increased by approximately $52 million to $2.03 billion, reflecting the impact of foreign currency translation.

In the six months ended June 28, 2025, other intangibles resulting from business acquisitions, net, decreased by approximately $39 million to $716.4 million, primarily reflecting current year amortization expense, partially offset by the impact of foreign currency translation.

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

Refer to Note 2, "Goodwill and Other Intangibles Resulting from Business Acquisitions," to the unaudited Condensed Consolidated Financial Statements for more information.

*Shareholders' Equity Accounts* 

As of June 28, 2025, the balance of our shareholders' equity was $2.20 billion. Refer to Note 8, "Supplemental Equity and Comprehensive Income Information," to the unaudited Condensed Consolidated Financial Statements for more information.

**Impact of Foreign Currency Translation** 

---

| | |
|:---|:---|
|<br>(In millions) | **Six Months Ended**<br>**June 28, 2025** |
| Change in net sales | $(45) |

---

International operations generated approximately 69% of our net sales during the six months ended June 28, 2025. Our future results are subject to changes in worldwide economic conditions, tariffs, social, geopolitical, and market conditions in the regions in which we operate and the impact of fluctuations in foreign currency exchange and interest rates.

The unfavorable impact of foreign currency translation on net sales in the first six months of 2025 compared to the same period last year was primarily related to sales in Brazil and Mexico.

**Effect of Foreign Currency Transactions**

The impact on net income from transactions denominated in foreign currencies is largely mitigated because the costs of our products are generally denominated in the same currencies in which they are sold. In addition, to reduce our income and cash flow exposure to transactions in foreign currencies, we enter into foreign exchange forward, option and swap contracts where available and appropriate. Refer to Note 5, "Financial Instruments," to the unaudited Condensed Consolidated Financial Statements for more information.

**Analysis of Selected Financial Ratios** 

We utilize the financial ratios discussed below to assess our financial condition and operating performance. We believe this information assists our investors in understanding the factors impacting our cash flow other than net income and capital expenditures.

*Operational Working Capital Ratio* 

Operational working capital, as a percentage of annualized current-quarter net sales, is reconciled to working capital (deficit) below. The working capital deficit (current assets minus current liabilities) as of the second quarter of 2024 was primarily due to our €500 million of senior notes due in the first quarter of 2025 and $300 million of senior notes due in the third quarter of 2024. Our objective is to minimize our investment in operational working capital, as a percentage of annualized current-quarter net sales, to maximize our cash flow and return on investment. As shown below, operational working capital, as a percentage of annualized current-quarter net sales, in the second quarter of 2025 increased compared to the second quarter of 2024.

---

| | | |
|:---|:---|:---|
| (In millions, except percentages) | **June 28, 2025** | **June 29, 2024** |
| (A) Working capital (deficit) | $121.7 | $(332.4) |
| Reconciling items: |  |  |
| &nbsp;&nbsp;Cash and cash equivalents | (215.9) | (208.8) |
| &nbsp;&nbsp;Other current assets | (314.5) | (250.5) |
| &nbsp;&nbsp;Short-term borrowings and current portion of long-term debt and finance leases | 922.0 | 1172.3 |
| &nbsp;&nbsp;Accrued payroll and employee benefits and other current liabilities | 832.6 | 814.5 |
| (B) Operational working capital | $1345.9 | $1195.1 |
| (C) Second-quarter net sales, annualized | $8882.0 | $8941.2 |
| Operational working capital, as a percentage of annualized current-quarter net sales: (B) ÷ (C) | 15.2% | 13.4% |

---

*Accounts Receivable Ratio* 

The average number of days sales outstanding was 67 days in the second quarter of 2025 compared to 62 days in the second quarter of 2024, calculated using the accounts receivable balance at quarter-end divided by the average daily sales in the respective quarter. The increase in average number of days sales outstanding was primarily due to the impact of customer destocking, timing of collections and impact of foreign currency translation.

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

*Inventory Ratio* 

Average inventory turnover was 6.2 in the second quarter of 2025 compared to 6.4 in the second quarter of 2024, calculated using the annualized second-quarter cost of products sold in 2025 and 2024, respectively, and divided by the inventory balance at quarter-end.

*Accounts Payable Ratio* 

The average number of days payable outstanding was 75 days in the second quarter of 2025 compared to 76 days in the second quarter of 2024, calculated using the accounts payable balance at quarter-end divided by the respective annualized second-quarter cost of products sold. The decrease in average number of days payable outstanding primarily reflected the timing of vendor payments, partially offset by the impact of foreign currency translation.

**Capital Resources** 

Capital resources used to fund our operational needs include cash flows from operations, cash and cash equivalents and debt financing, including access to commercial paper borrowings supported by our $1.20 billion revolving credit facility (the "Revolver").

The Revolver is used as a back-up facility for our commercial paper borrowings and can be used for other corporate purposes. No balance was outstanding under the Revolver as of June 28, 2025 or December 28, 2024.

As of June 28, 2025, we had cash and cash equivalents of $215.9 million held in accounts at third-party financial institutions. Our cash balances are held in numerous locations around the world. As of June 28, 2025, the majority of our cash and cash equivalents was held by our foreign subsidiaries, primarily in Asia Pacific.

To meet our U.S. cash requirements, we have several cost-effective liquidity options available. These options include borrowing funds at reasonable rates, including borrowings from foreign subsidiaries, and repatriating foreign earnings and profits. However, if we were to repatriate foreign earnings and profits, a portion would be subject to cash payments of withholding taxes imposed by foreign tax authorities. Additional U.S. taxes may also result from the impact of foreign currency fluctuations related to these earnings and profits.

*Capital from Debt* 

The carrying value of our total debt increased by approximately $398 million in the first six months of 2025 to $3.55 billion, primarily reflecting higher commercial paper borrowings and the revaluation of our euro-denominated debt, partially offset by the repayment of our €500 million of senior notes and our $25 million of medium-term notes at their maturity in the first and second quarters of 2025, respectively.

Credit ratings are a significant factor in our ability to raise short- and long-term financing. The credit ratings assigned to us also impact the interest rates we pay and our access to commercial paper, credit facilities and other borrowings. A downgrade of our short-term credit ratings could impact our ability to access commercial paper markets. If our access to commercial paper markets were to become limited, we believe that the Revolver and our other credit facilities would be available to meet our short-term funding requirements. When determining a credit rating, we believe that rating agencies primarily consider our competitive position, business outlook, consistency of cash flows, debt level and liquidity, geographic dispersion and management team. We remain committed to maintaining an investment grade rating.

**Off-Balance Sheet Arrangements, Contractual Obligations, and Other Matters** 

Refer to Note 10, "Commitments and Contingencies," to the unaudited Condensed Consolidated Financial Statements for this information. Except as indicated therein, we have no material off-balance sheet arrangements as described in Item 303(b) of Regulation S-K.

**ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK** 

There have been no material changes to the information provided in Part II, Item 7A of our Annual Report on Form 10-K for the fiscal year ended December 28, 2024 that have not been disclosed in our periodic filings with the SEC.

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

**ITEM 4. CONTROLS AND PROCEDURES** 

**Evaluation of Disclosure Controls and Procedures** 

We maintain disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(f)) that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding the required disclosure.

In designing and evaluating the disclosure controls and procedures, we recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Our disclosure controls system is based upon a global chain of financial and general business reporting lines that converge in our headquarters in Mentor, Ohio. As required by SEC Rule 13a-15(b), we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the quarter covered by this report. Based on the foregoing, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of such time to provide reasonable assurance that information was recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and that such information was accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding the required disclosure.

**Changes in Internal Control Over Financial Reporting** 

There were no changes in our internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

**PART II. OTHER INFORMATION** 

**ITEM 1. LEGAL PROCEEDINGS** 

Refer to "Legal Proceedings" in Note 10, "Commitments and Contingencies," to the unaudited Condensed Consolidated Financial Statements in Part 1, Item 1 for this information.

**ITEM 1A. RISK FACTORS** 

There have been no material changes to the risk factors included in Part I, Item 1A, of our Annual Report on Form 10-K for the fiscal year ended December 28, 2024 that have not been disclosed in our periodic filings with the SEC, except as set forth below.

**The demand for our products is impacted by the effects of, and changes in, worldwide economic, social, geopolitical and market conditions, and tariffs and related countermeasures, which could have a material adverse effect on our business.**

We have operations in more than 50 countries and our domestic and international operations are strongly influenced by matters beyond our control, including changes in geopolitical, social, economic and labor conditions, tax laws, and U.S. and international trade regulations (including tariffs), as well as the impact these changes have on demand for our products. In 2024, approximately 70% of our net sales were produced in international operations.

Macroeconomic developments such as impacts from slower growth in the geographic regions in which we operate; inflation, resulting from, among other things, increased raw material, energy, and freight costs; labor shortages; geopolitical, social, supply chain and other disruptions; epidemics, pandemics or other outbreaks of illness, disease or virus; and uncertainty in the global credit or financial markets could result in a material adverse effect on our business as a result of, among other things, lower consumer spending, fluctuations in foreign currency exchange rates, reduced asset valuations, diminished liquidity and credit availability, volatility in securities prices, and credit rating downgrades.

Tensions remain in trade relations between the U.S. and other regions and countries, including Canada, Mexico, China and the European Union. In 2025, the U.S. implemented a 10% global baseline tariff rate on nearly all U.S. imports, with higher rates on certain goods. Additionally, it imposed significant tariffs on goods from Canada, Mexico, China and the European Union, each of which announced and/or imposed reciprocal tariffs. The amount of these tariffs or the classes of goods on which they are imposed could significantly increase. The U.S. government continues to negotiate with countries regarding the tariffs; to enable these negotiations, it paused certain of these tariffs until August 1, 2025. On July 27, 2025, the U.S. and the European Union agreed to a framework for a trade deal that included a baseline tariff rate of 15% on most goods imported from the European Union into the U.S. While the direct impacts on our operations after our mitigating actions have not been significant, our business could be materially adversely impacted by changes in U.S. and non-U.S. trade policies, including potential modifications to existing trade agreements and additional tariffs or other restrictions on free trade, impacting our raw materials or finished products. The indirect impact on demand for our products and solutions as a result of these events, which negatively impacted sales in overall apparel categories in the second quarter of 2025, is more uncertain and elevated as the outlook for global gross domestic product growth has reduced. Further developments in international trade relations could have a material adverse effect on our business.

In addition, business and operational disruptions or delays caused by geopolitical, social or economic instability and unrest – such as recent civil, political and economic disturbances in Argentina, Afghanistan, Syria, Iraq, Yemen, Iran, Turkey, North Korea, and Bangladesh and the related impact on global stability, the Russia-Ukraine war, the Israel-Hamas war, terrorist attacks and the potential for other hostilities or natural disasters in various parts of the world – could contribute to a climate of economic and geopolitical uncertainty that could have a material adverse effect on our business. Since the Russia-Ukraine war began in February 2022, we have maintained our position of not shipping products to the Russian market. The impact of the continuing war, as well as any further retaliatory actions taken by Russia, the U.S., the European Union and other jurisdictions, is unknown and could have a material adverse effect on our business. In addition, since the beginning of the Israel-Hamas war in late 2023; our sales in Israel have declined, with sales representing less than 1% of our total net sales in 2024. We have experienced some disruptions in our operations in Israel and the Middle East and implemented plans to address these disruptions, as well as the impacts thereof in Gaza, Lebanon and other areas of the Middle East, while focusing on the continued safety of our Israeli employees and their families. The continued impact of this war and any related hostilities in the Middle East region or elsewhere is unknown and could have a material adverse effect on our business.

We are not able to predict the duration and severity of adverse economic, social, geopolitical or market conditions in the U.S. or other countries.

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

**ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS**

(a)Not Applicable

(b)Not Applicable

(c)Repurchases of Equity Securities by Issuer

Repurchases by us or our "affiliated purchasers" (as defined in Rule 10b-18(a)(3) of the Exchange Act) of registered equity securities in the second quarter of 2025 are shown in the table below. Repurchased shares may be reissued under our long-term incentive plan or used for other corporate purposes.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period**<sup>(1)</sup> | **Total number**<br>**of shares**<br>**purchased**<sup>(2)</sup> | **Average**<br>**price paid**<br>**per share**<sup>(3)</sup> | **Total number of shares**<br>**purchased as part of**<br>**publicly announced**<br>**plans**<sup>(2)(4)</sup>  | **Approximate dollar**<br>**value of shares that may**<br>**yet be purchased under**<br>**the plans**<sup>(4)(5)</sup> |
| March 30, 2025 – April 26, 2025 | 397.7 | $169.86 | 397.7 | $769.9 |
| April 27, 2025 – May 24, 2025 | 49.5 | 177.39 | 49.5 | 761.1 |
| May 25, 2025 – June 28, 2025 | 119.5 | 177.59 | 119.5 | 739.9 |
| Total | 566.7 | $172.15 | 566.7 | $739.9 |

---

<sup>(1)</sup> The periods shown are our fiscal months during the thirteen-week quarter ended June 28, 2025.

<sup>(2)</sup> Shares in thousands.

<sup>(3)</sup> Average price paid per share includes transaction costs to acquire the shares and excludes the non-deductible 1% excise tax on the net value of repurchases imposed under the Inflation Reduction Act of 2022.

<sup>(4)</sup> In April 2022, our Board authorized the repurchase of shares of our common stock with a fair market value of up to $750 million, excluding any fees, commissions or other expenses related to such purchases and in addition to the amount outstanding under our previous Board authorization. In April 2025, our Board authorized the repurchase of shares of our common stock with a fair market value of up to $750 million, excluding any fees, commissions or other expenses related to such purchases and in addition to the amount outstanding under our previous Board authorization. Board authorizations remain in effect until shares in the amount authorized thereunder have been repurchased.

<sup>(5)</sup> Dollars in millions.

**ITEM 3. DEFAULTS UPON SENIOR SECURITIES** 

Not Applicable

**ITEM 4. MINE SAFETY DISCLOSURES** 

Not Applicable

**ITEM 5. OTHER INFORMATION** 

There were no Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements (as defined in Item 408(c) of Regulation S-K) adopted or terminated by any of our directors or executive officers during the second quarter of 2025.

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

**ITEM 6. EXHIBITS** 

---

| | |
|:---|:---|
| Exhibit 3.1 | <u>[Amended and Restated Certificate of Incorporation, as filed on April 28, 2011 with the Office of Delaware Secretary of State (incorporated by reference to Exhibit 3.1 of the Company's Current Report on Form 8-K filed on April 29, 2011).](https://www.sec.gov/Archives/edgar/data/8818/000129993311001274/exhibit1.htm)</u> |
| Exhibit 3.2 | <u>[Certificate of Amendment to Amended and Restated Certificate of Incorporation of Avery Dennison Corporation, effective as of April 25, 2024 (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed on April 26, 2024).](https://www.sec.gov/Archives/edgar/data/8818/000000881824000007/ex318k4-26x24.htm)</u> |
| Exhibit 3.3 | <u>[Amended and Restated Bylaws of Avery Dennison Corporation, effective as of April 25, 2024 (incorporated by reference to Exhibit 3.2 to the Company's Current Report on Form 8-K filed on April 26, 2024).](https://www.sec.gov/Archives/edgar/data/8818/000000881824000007/ex328k4-26x24.htm)</u> |
| Exhibit 31.1\* | <u>[Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](avy-2025729x10qex311.htm)</u> |
| Exhibit 31.2\* | <u>[Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](avy-2025729x10qex312.htm)</u> |
| Exhibit 32.1\*\* | <u>[Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](avy-2025729x10qex321.htm)</u> |
| Exhibit 32.2\*\* | <u>[Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](avy-2025729x10qex322.htm)</u> |
| Exhibit 101.INS\*\*\* | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
| Exhibit 101.SCH\*\*\* | Inline XBRL Extension Schema Document |
| Exhibit 101.CAL\*\*\* | Inline XBRL Extension Calculation Linkbase Document |
| Exhibit 101.LAB\*\*\* | Inline XBRL Extension Label Linkbase Document |
| Exhibit 101.PRE\*\*\* | Inline XBRL Extension Presentation Linkbase Document |
| Exhibit 101.DEF\*\*\* | Inline XBRL Extension Definition Linkbase Document |
| Exhibit 104\*\*\* | Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included as part of this Exhibit 101 Inline XBRL document set |

---

____________________

\* Filed herewith.

\*\* Furnished herewith.

\*\*\* Furnished herewith. Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act, are deemed not filed for purposes of Section 18 of the Exchange Act and otherwise are not subject to liability under those sections.

------

**<u>[**Table of Contents**](#ib07a0b00f720416bae77b66ae569d11e_7)</u>**

Avery Dennison Corporation

**SIGNATURES** 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| |
|:---|
| AVERY DENNISON CORPORATION |
| (Registrant) |
| /s/ Gregory S. Lovins |
| Gregory S. Lovins |
| Senior Vice President and Chief Financial Officer |
| (Principal Financial Officer) |
| /s/ Divina F. Santiago |
| Divina F. Santiago |
| Vice President, Controller |
| (Principal Accounting Officer) |
| July 29, 2025 |

---

## Exhibit 31.1

Avery Dennison Corporation

**Exhibit 31.1**

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER**

**PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

**<u>CERTIFICATION</u>**

I, Deon M. Stander, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Avery Dennison Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d)disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| | /s/ | Deon M. Stander |
| | Deon M. Stander<br>President and Chief Executive Officer | Deon M. Stander<br>President and Chief Executive Officer |
| July 29, 2025 | | |

---

## Exhibit 31.2

Avery Dennison Corporation

**Exhibit 31.2**

**CERTIFICATION OF CHIEF FINANCIAL OFFICER**

**PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

**<u>CERTIFICATION</u>**

I, Gregory S. Lovins, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Avery Dennison Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d)disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| | /s/ | Gregory S. Lovins |
| | Gregory S. Lovins<br>Senior Vice President and Chief Financial Officer | Gregory S. Lovins<br>Senior Vice President and Chief Financial Officer |
| July 29, 2025 | | |

---

## Exhibit 32.1

Avery Dennison Corporation

**Exhibit 32.1**

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER\***

**PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)the Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended June 28, 2025 (the "Report") fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Dated: July 29, 2025 | | |
| | /s/ | Deon M. Stander |
| | Deon M. Stander<br>President and Chief Executive Officer | Deon M. Stander<br>President and Chief Executive Officer |

---

\*The above certification accompanies the Company's Quarterly Report on Form 10-Q and is furnished, not filed, as provided in SEC Release 33-8238, dated June 5, 2003.

## Exhibit 32.2

Avery Dennison Corporation

**Exhibit 32.2**

**CERTIFICATION OF CHIEF FINANCIAL OFFICER\***

**PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)the Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended June 28, 2025 (the "Report") fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Dated: July 29, 2025 | | |
| | /s/ | Gregory S. Lovins |
| | Gregory S. Lovins<br>Senior Vice President and Chief Financial Officer | Gregory S. Lovins<br>Senior Vice President and Chief Financial Officer |

---

\*The above certification accompanies the Company's Quarterly Report on Form 10-Q and is furnished, not filed, as provided in SEC Release 33-8238, dated June 5, 2003.

<br>